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Wisdom is the awareness 
that while you are defined by what lies within your sphere, 
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The incidence and long-term effects of traumatic brain injury (TBI) make it a major 
healthcare and socioeconomic concern.  Cell transplantation may be an alternative 
therapy option to target prolonged neurological deficits; however, safety and efficacy of 
the cells must be determined.  Bone marrow-derived mesenchymal stem cells (MSCs) 
are an accessible and expandable cell source which circumvent the many of the 
accessibility and ethical concerns associated with fetal tissues.  A major impediment to 
recent clinical trials for cell therapies in the central nervous system has been the lack of 
consistency in functional recovery where some patients receive great benefits while 
others experience little, if any, effect (Watts and Dunnett 2000; Lindvall and Bjorklund 
2004).  There are many possible explanations for this patient-to-patient variability 
including genetic and environmental factors, surgical techniques, and donor cell 
variability.  Of these, the most easily addressable is to increase the reproducibility of 
donor cells by standardizing the isolation and pre-transplantation protocols, which is the 
central goal of this dissertation.  First, we present an animal study in which transplants of 
MSCs and neural stem cells (NSCs) were given to brain-injured mice, however, the 
efficacy of the treatment had high variability between individual subjects.  Second, we 
designed a method to produce MSC-spheres and characterize them in vitro.  Last, we 
employed an in vitro 3-D culture testbed as a pre-transplant injury model to assess the 
effects of the MSC-spheres on neural cells.  The electrophysiological function of the 
uninjured testbed was assessed, and then MSC-spheres were injected into the testbed 
and apoptosis of the host cells were measured. The results of this study contribute to our 
understanding of how extracellular context may influence MSC-spheres and develop 






Approximately 1 in 50 United States citizens are currently living with a permanent TBI-
related disability (CDC 1999).  The lack of clinically successful therapies is due at least 
in part to the number of different cell populations that are compromised upon injury.  
Reconstructing the original heterogeneous organization has proved difficult so far 
however; the multipotential and adaptable nature of stem cells suggests that they might 
provide therapeutic value for the multiple pathological events in TBI over a sustained 
period.  The harvest of adult stem cells from bone marrow provides a potential graft 
source with minimal ethical, immunological or accessibility concerns.  Preceding the 
clinical implementation of MSC therapy, cell-specific transplant parameters must be 
determined including adopting standardized, reproducible donor cell isolation and 
expansion protocols.  In addition, low donor cell survival need to be addressed.  One 
approach to provide MSCs with the signals and support they need to survive and 
influence host neural tissue is transplantation of the stem cells as multicellular 
aggregates within bioactive tissue-engineered constructs.  Once transplant parameters 




Traumatic Brain Injury  
Epidemiology 
Traumatic brain injury (TBI) is a major contributor to morbidity and mortality in our 
society.  In the United States alone, over 50,000 people are killed and nearly another 
80,000 are significantly disabled by TBI each year with the highest incidence occurring in 
the 15 to 24 year age group (CDC 1999).  Rehabilitation efforts may be extensive as 
many TBI survivors are physically disabled, suffer memory loss, or acquire psychological 
disorders (Thurman et al. 1999).  In 1995, TBI-related injuries had an estimated annual 
expense of $56 billion per year in direct and indirect costs (e.g. lost work hours, etc) 
(Thurman 2001).  Since TBI has been named the hallmark injury of modern day war, the 
incidence and associated costs are projected to rise (Warden 2006).  TBI has been 
identified as a critical public health concern, and the Public Health Service has made the 
decrease of TBI hospitalizations a focused objective in Healthy People 2010, an annual 
report which outlines national health and disease prevention goals in the United States. 
 
Treatment Options for TBI 
Current Treatment Strategies 
Although the health and socioeconomic impact of TBI is great, current treatment options 
are limited.  Most current clinical treatments are pharmaceutical in nature and focus on 
reduction of acute sequelae, such as controlling intracranial pressure and bleeding.  
Several pharmacological treatments have been explored for TBI treatment including 
compounds which aim to attenuate excitotoxity, decrease calcium release, scavenge 
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reactive oxygen species, decrease inflammation, inhibit pro-apoptotic cascades, correct 
neuroendocrine and neurotransmission abnormalities, increase neurotrophins, reduce 
seizures, or reduce ischemia (for review see (Marklund et al. 2006)).  Unfortunately, 
none of the Phase III clinical trials to date demonstrate a significant improvement in 
outcome following TBI (Marklund et al. 2006), and the current standard of care following 
TBI is primarily supportive and palliative.  After a meta-analysis of the recent current 
research, The 2007 Guidelines for the Management of Severe Traumatic Brain Injury 
recommend maintaining adequate blood pressure and monitoring intercranial pressure.  
Elevated intercranial pressure should be reduced by the use of mannitol, hyperosmolar 
saline, barbiturates, sedatives, or hyperventilation (2007).  Several other therapies 
including prophylactic hyperthermia, antibiotics, or hyperventilation have been used with 
variable results, however pooled data suggest that none of these result in a decrease in 
overall mortality (2007).  While there has been an overall improvement in prognosis for 
TBI victims in recent years, none the most common current interventions used clinically 
have been shown to reliably reduce morbidity and mortality after severe TBI (Roberts et 
al. 1998; Marklund et al. 2006) nor do they address the loss of cells in the brain directly. 
 
Therapeutic Considerations 
Difficulty in creating clinically effective treatment options stems partly from the fact that 
the injury is multifaceted.  Besides the acute effects from primary brain deformation, 
secondary cascades are complex and may increase inflammatory response, alter cell 
signaling and gene expression, and cause cell death in surrounding tissues (McIntosh et 
al. 1998; Verma 2000).  This secondary cascade, which results in sustained 
complications including inflammation, excitotoxicity, and breakdown of the blood-brain 
barrier, may result in cell death for months after the initial traumatic event (Conti et al. 
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1998; Bramlett and Dietrich 2002).  In addition, axonal degeneration has been observed 
by histological analysis up to a year post-injury in the cortex, striatum, and corpus 
callosum following fluid percussion injury (Pierce et al. 1998).  While much of the cell 
death immediately following the primary injury is necrotic, the post-injury environment 
also activates apoptotic pathways (Wong et al. 2005; Zhang et al. 2005; Byrnes and 
Faden 2007).  The resulting secondary cascades may promote a progressive, 
degenerative condition in the brain following TBI.  Treatment strategies designed to 
attenuate the progressive cell loss and encourage regeneration are likely to be broad in 




One attractive treatment option is the delivery of cells to the injury site (Schouten et al. 
2004).  Transplanted cells may facilitate recovery by counteracting the deleterious 
effects within the injury environment, providing continuous trophic support to injured 
cells, participating in pro-survival cell-cell signaling, and/or replacing neural cells lost 
during the injury.  Clinical trials of transplanted cells have shown some promise for the 
treatment of severe brain injury (Seledtsov et al. 2005); however, cell therapy has an 
inherent variability.  Although host individuality certainly plays a role, the donor cell 
contribution to this variability cannot be ignored, and may even supercede host 
contribution in terms of influence on donor cells survival, phenotype, and function (Watts 
and Dunnett 2000; Lindvall and Bjorklund 2004).  Therefore, the choice of a cell source, 




Donor Cell Sources for Transplantation 
Fetal Tissue Transplantation 
Transplantation of fetal tissues into animals receiving central nervous system (CNS) 
trauma and neurodegeneration has shown some functional recovery (for review see 
(Koutouzis et al. 1994; Subramanian 2001)).  In brain trauma specifically, fetal cortical 
tissue transplants improved functional recovery following frontal cortical lesions (Labbe 
et al. 1983) or fluid percussion injury (Sinson et al. 1996).  Despite these promising 
results, there are several ethical and practical issues which limit the clinical applicability 
of fetal tissue grafts (for review see (Stein 1991; Stein and Glasier 1995)).  One of the 
major limitations is the availability of fetal tissue and ethical concerns surrounding its 
procurement.  Another practical consideration is the invasive intercranial surgery 
required to place such transplants and the short time window that brain tissue remains 
viable ex vivo.  Therefore, a more feasible option may be an injectable suspension of 
non-fetal cells. 
 
Stem Cell Transplantation 
Transplantation of cell suspensions may have several advantages over tissue grafts, 
however the choice of a donor cell source is significant, and there are several options 
with advantages and limitations to each. 
 
Embryonic Stem Cells 
Embryonic stem cells have the advantage of having the potential to differentiate into 
multiple phenotypes, including neurons, given the correct signals (Guan et al. 2001; Kim 
et al. 2007).  Transplantation of embryonic stem cells in animals following TBI has 
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improved motor and cognitive recovery, however tumors were also found in multiple 
subjects (Riess et al. 2007).  Clinical trials of embryonic stem cell therapy in Parkinson’s 
disease has had some success in individual patients, but has also had high patient-to-
patient variability and late developing immune responses, which have curbed 
enthusiasm (Bjorklund 2005; Winkler et al. 2005).  In addition, because embryonic stem 
cells are embryonically-derived, and the ethical procurement and use of embryos is 
fiercely debated and tissue is difficult to obtain in sufficient quantity, therefore, alternative 
donor cell sources are an attractive option. 
 
Neural Stem Cells 
The use of neural stem cells (NSCs) for neurotransplantation has been well-studied in 
animal models for multiple neurological disorders including neurodegenerative diseases, 
stroke, and trauma (for review see (Lim et al. 2007)).  NSCs are more committed than 
embryonic stem cells and give rise to the three major cell types in the central nervous 
system: neurons, astrocytes, and oligodendrocytes (Kallos et al. 2003).  While neural 
stem cells can be isolated from multiple brain regions and ages (for review see 
(Kornblum 2007)), most are still harvested from embryonic or fetal tissues.  In addition, 
since they are isolated from interior regions of the brain, the harvest is highly invasive 
and allows limited potential for autologous transplantation (Taupin 2006).  
 
Adult Stem Cells 
Besides avoiding most of the ethical dilemmas surrounding embryonic tissues, studies 
have shown that adult stem cells may retain much of the multipotentiality of their 
embryonic and fetally-derived counterparts.  There are many sources for adult stem cells 
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including the umbilical cord, adipose tissue, and certain regions of the adult brain; 
however, the most accessible and least invasive source is bone marrow. 
 
Bone Marrow-Derived Mesenchymal Stem Cells  
Definition of MSCs 
Within the bone marrow there are many cell types including hematopoetic stem cells and 
mesenchymal stem cells (MSCs).  Hematopoetic stem cells are responsible for re-
populating the bone marrow and blood.  MSCs are non-hematopoetic stem-like cells 
capable of differentiating into multiple cell types of mesenchymal and non-mesenchymal 
origin (Prockop 1997; Mezey et al. 2000; Herzog et al. 2003).  While there is not a single 
marker to identify MSCs, they are generally defined by a combination of physical, 
phenotypic, and functional properties including the lack of hematopoetic markers and 
ability to differentiate into osteoblasts and adipocytes.  While there are multiple similar 
definitions of MSCs and related cell types isolated from the bone marrow, this is one we 
will use here.  
 
Advantages to Adult Stem Cells 
Recent advances in stem cell research suggest that adult sources of tissue grafts retain 
the plasticity necessary for regenerative medicine applications while avoiding many of 
the ethical, immunological, and accessibility concerns surrounding embryonic tissues or 
xenografts.  Bone marrow harvests and transplants have been successful for decades, 
and autologous transplants, as well as allogenic transplants, are performed regularly.  
Post-mortem analysis of human brain tissue has found transgender neurons and 
astrocytes after sex-mismatched bone marrow transplants (Mezey et al. 2003; Cogle et 
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al. 2004; Sostak et al. 2007) and similar results were obtained in uninjured mice 
(Brazelton et al. 2000; Mezey et al. 2000) suggesting that bone marrow may be a natural 
source of neural regeneration.  Furthermore, MSCs may have multiple desirable 
immunomodulatory effects as neither undifferentiated nor differentiated MSCs elicit 
significant lymphocyte proliferation (Bartholomew et al. 2002; Le Blanc et al. 2003; Liu et 
al. 2006a) and may even inhibit T-cell activation (Glennie et al. 2005).  In addition, MSC 
transplantation in severe graft-verses-host-disease has shown significant improvement 
(Le Blanc et al. 2004) implying that although autologous MSC transplants are optimal, 
allogenic transplants may also be possible without significant immune rejection, 
increasing clinical flexibility for graft sources in individual patients. Together, these 
studies suggest the feasibility and flexability for clinical applications of MSCs may 
surpass embryonic or neural stem cells. 
 
Transplantation of MSCs in the Central Nervous System 
Bone marrow-derived MSCs have been shown to be capable of self-proliferation and 
differentiation into multiple cell types including neural progenitor cells (Prockop 1997; 
Mezey and Chandross 2000; O'Connor et al. 2000b; Jiang et al. 2002a; Verfaillie 2002; 
Herzog et al. 2003).  MSCs may be related to another type of bone marrow-derived cell, 
multipotent adult progenitor cells or MAPCs, which have also been shown to possess 
multipotenitality (Jiang et al. 2002a; Jiang et al. 2002b; Verfaillie 2002).  Transplanted 
MSCs in animal models of stroke, TBI, spinal cord injury, and neurodegenerative 
disorders have shown improved functional recovery on behavioral tests (for review see 
((Corti et al. 2003; Dezawa 2006; Tang et al. 2007)); however, the variability in long-term 
outcomes is often great.  There are many sources of variability within behavioral 
outcome studies in animal models and clinical trials (Watts and Dunnett 2000; Lindvall 
 9 
and Bjorklund 2004).  While patient-to-patient variability certainly plays a role, variability 
of the donor cells may also contribute in large part.  MSCs are a small proportion of the 
heterogeneous population of bone marrow from which they are harvested, and isolation 
protocols can yield anywhere from a fairly pure population of stem cells to a 
heterogeneous mix.  Variability may be improved by using a more stringent isolation 
method and reproducible culture conditions to obtain a more homogeneous population of 
cells prior to transplantation.  
 
Extracellular Influences to Mesenchymal Stem Cell Fate 
The cellular differentiation process has not been fully explained, however, it is evident 
that complex cell-cell and cell-ECM interactions contribute to the development and 
function of MSCs (Fried et al. 1996; Gronthos et al. 2001), and studies by many 
investigators suggest survival, proliferation, and differentiation are the result of multiple 
soluble factors and substrate signals (for review see (Corti et al. 2003)).  Most MSC 
transplantations to date have been of single cell suspensions in a saline solution; 
however, with the overall goal to increase MSC survival and function post-transplant, it 
may be beneficial to transplant cells in multicellular aggregates within a bioactive matrix 
to stimulate pro-survival, migration, and differentiation signals.  
 
Extracellular Matrix 
Tissue-engineered constructs may increase cell survival and promote differentiation by 
providing transplanted cells with attachment sites similar to those normally found in the 
extracellular matrix (ECM).  The availability of attachment sites has been shown to 
improve cell survival and integration of neural cells (Saporta et al. 1997; Chauhan et al. 
1999).  This may be mediated in part by membrane bound receptors such as integrins 
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which play a role in regulating survival, proliferation, and differentiation (Danen and 
Yamada 2001). One study showed significant difference in MSC proliferation on tissue 
culture dishes coated with laminin, fibronectin, collagen, or Matrigel over those plated on 
poly-D-lysine (Qian and Saltzman 2004).  In another study, the combination of 
fibronectin-coated dishes and soluble fibroblast growth factor and retinoic acid resulted 
in 40% of the cells expressing neurofilament-M (Kim et al. 2002).   
 
Furthermore, transplanting cells within a thermal-reversible polymer that is a viscous 
liquid at room temperature but becomes a soft gel at 37ºC may have advantages over 
cells injected in solution including 1) buffering of detrimental factors from surrounding 
tissues, 2) the ability to fill irregularly-shaped cavities, and 3) a decreased tendency to 
leak out of the injection path.  Intercellular signaling cascades are complex, yet 
developmental biology has shown that cells receive signals from soluble factors and 
their immediate extracellular environment that affect survival, migration, and 
differentiation.  However, the interaction between MSCs and their ECM has not been 
fully characterized, particularly in the brain. 
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CHAPTER 2 
BONE MARROW-DERIVED MESENCHYMAL STEM CELLS 
AS AN ALTERNATE DONOR CELL SOURCE FOR 
TRANSPLANTATION INTO TRAMATICALLY INJURED BRAINS 
 
2.1 Introduction 
Traumatic brain injury (TBI) has widespread socioeconomic effects and causes long-
term damage to affected individuals (CDC 1999; Thurman 2001).  The injury is difficult to 
treat as the insult usually results in the loss of multiple cell types within the brain, and no 
clinically effective treatments have been identified that ameliorate the long-term effects 
of TBI (Roberts et al. 1998).  One attractive treatment option is the transplantation of 
stem cells. 
 
Tissue-engineered constructs consisting of cells within a scaffold may increase cellular 
survival following transplant by providing increased cell-cell and cell-matrix cellular 
adhesion points.  A scaffold which is inherently bioactive separate from the transplanted 
cells may also provide some benefit to the host such as buffering host tissue from 
secondary injury cascades and inflammatory response.  A thermo-reversible scaffold 
which gels in situ also has the added benefit of trapping the cells during transplantation 
to minimize leakage back through the needle track.  Laminin promotes neurite outgrowth 
in the developing brain and has been used in CNS scaffolds (Yu et al. 1999; Stabenfeldt 
et al. 2006).  Scaffolds containing laminin and collagen type I have shown increased 
cellular survival of NSCs when transplanted into the injured brain compared to cells in 
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suspension (Tate et al. 2002).  Therefore, we utilized a laminin-containing scaffold for 
transplantation. 
 
Neural stem cell (NSC) transplantation has shown promising results as a treatment 
option in multiple brain disorders including TBI (Shear et al. 2004), however since NSCs 
are fetally-derived, the cell source is a point of concern for clinical application.  Bone 
marrow-derived mesenchymal stem cells (MSCs) have recently been shown to retain the 
plasticity necessary for regenerative medicine while avoiding many of the accessibility, 
political, and ethical issues surrounding fetally-derived graft sources(Prockop 1997; 
Bjornson et al. 1999).  In addition, the technology required for bone marrow transplants 
has progressed to the point where autografts and allografts of bone marrow cells are 
routinely preformed.  The bone marrow may also be a natural source of regeneration as 
bone marrow-derived cells have been found post-mortem in the brains of bone marrow 
transplant recipients who have also suffered head trauma (Mezey et al. 2003; Cogle et 
al. 2004; Sostak et al. 2007) and similar results have been found in mice (Brazelton et al. 
2000; Mezey et al. 2000). 
 
In order to adopt a new cell source for transplantation, it must first be compared to the 
“gold standard” cell source to determine if the feasibility and effectiveness of the new 
donor cell source.  In our laboratory, we have used NSCs as donor cells for 
transplantation into a traumatically-injured mouse and have observed long-term 
behavioral recovery (Tate et al. 2002; Shear et al. 2004; Tate et al. 2004).  We have also 
developed extracellular matrix protein-containing scaffolds for delivery of the donor cells 
(Tate et al. 2001; Stabenfeldt et al. 2006).  Here, we compare NSCs to MSCs as 




Experimental Model - Controlled Cortical Impact Injury 
The controlled cortical impact (CCI) device delivers a controlled mechanical 
compression to the cortical surface of the brain of adult animals which produces 
histopathology consistent with cortical contusion in human TBI (Dixon et al. 1991).  This 
well-characterized experimental model produces consistent and reproducible injuries in 
adult animals, and motor and cognitive deficits of injured animals mimic certain aspects 
of human TBI patients including acute subdural hematoma, blood brain barrier 
disruption, and edema (Fox et al. 1998; Shear et al. 2004).  Using the CCI model, the 
investigator can control velocity, depth, duration, and angle of impact, although injury 
severity can best be predicted by velocity and depth of impact (Cernak 2005; Morales et 
al. 2005).  Parameters for a moderate injury (6.0 m/s; 1 mm depth) were used here, 
which causes cortical and subcortical damage considered moderate for a mouse model, 
and produces sustained sensorimotor and spatial learning deficits (Fox et al. 1998).  The 
CCI injury model used in this work is a custom-built pneumatically-driven impactor 
device (see Figure 2.1) with the following moderate injury parameters: 6.0 m/s velocity, 






Figure 2.1: Schematic of controlled cortical contusion device for producing 
traumatic injuries in mice.  This custom built device uses compressed air at 110 psi to 
deliver a controlled impact to the exposed mouse cortex with the dura intact.  The 
compressed air from the cylinder drives the piston down and then up as it moves though 
two distinct port on the double solenoid valve.  The device is controlled by LabVIEW 
software (National Instruments, Austin, TX) that also gives a reading of the duration and 
velocity from the linear voltage displacement transducer (LVDT).  (Schematic provided 
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Mesenchymal Stem Cell Culture 
Harvest and Isolation of MSCs 
MSCs were isolated and harvested as described before (Peister, et al. 2004) with slight 
modifications.  Whole bone marrow was isolated from the femurs and tibias of 8-10 week 
old male GFP+ transgenic C57BL/6-Tg(cAG-EGFP)C14-701-FM1310sb (C57BL6 
background) mice bred in house.  Mice were sacrificed, and bones were dissected out 
and cleaned of muscle and connective tissue.  One end of the bone was clipped and the 
bone marrow extracted by centrifugation.  The pellet from each bone was re-suspended 
in cell isolation media (CIM; RPMI-1640, 10% fetal bovine serum (FBS), and 10% horse 
serum), mechanically dissociated with a 22-gauge needle, filtered through a 70 µm filter, 
and plated in a T175 flask.  At 24 hours, non-adherent cells were removed, cells were 
rinsed with saline, and fresh CIM was added.  Cells were fed every 3-4 days. After 4 
weeks, cells were trypsinized for 2 minutes and re-plated in CIM in a T175 flask. Cells 
that did not detach in 2 minutes were discarded.  After 2 weeks, cells were trypsinized 
for 2 minutes and re-plated in 100 mm tissue culture dishes at a density of 50-500 
cells/cm2 in cell expansion media (CEM; IMDM, 10% FBS, and 10% horse serum).  
Once passage 3 cells were confluent, they were either expanded further in 100mm 
dishes or frozen (FBS + 10%DMSO).  Cells were used at passages 4-10.  
 
Priming of MSCs for Transplantation 
MSCs were expanded to 80-90% confluency in 100 mm tissue culture dishes.  Cells 
were trypsinized, and plated in NeuroBasal A (Invitrogen, Carlsbad, CA) supplemented 
with serum substitute B27 (Invitrogen), insulin (25 µg/mL), transferrin (100 µg/mL), 
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putrescine (60 µM), sodium selenite (30 nM), progesterone (20 nM), and L-glutamine (2 
mM) in T25 tissue culture flasks.  Human recombinant basic fibroblast growth factor 
(bFGF; 20 ng/mL; PreproTech, Rocky Hill, NJ) was added to the media every 2-3 days.   
As cells began to rise from the culture surface, flasks were knocked sideways against 
the lab bench to dislodge cell aggregates. 
 
Neural Stem Cell Culture 
Harvest and Isolation of NSCs 
Neural stem cells were harvested from transgenic C57BL/6-Tg(cAG-EGFP)C14-701-
FM1310sb mice (C57BL6 background) mice bred in house.  Pregnant mice were 
sacrificed by guillotine and embryos were isolated by Caesarian section at gestational 
day 14.5.  The skull was removed and parasagital cuts were made to expose the 
germinal layer.  Using a dissection microscope, the ganglionic eminence of the germinal 
zone was separated.  Tissue was mechanically dissociated by a flame-narrowed Pasteur 
pipette in Hank’s balanced salt solution (HBSS).  Cells were cultured as neurospheres in 
tissue culture flasks in Dulbecco’s modified eagle medium: nutrient mixture F-12 
(DMEM/F12, 1:1; Invitrogen) supplemented with insulin (25 µg/mL), transferrin (100 
µg/mL), putrescine (60 µM), sodium selenite (30 nM), progesterone (20 nM), and 
glucose (0.3%).  Human recombinant basic fibroblast growth factor (bFGF; 20 ng/mL; 
PreproTech) was added to the media every 2-3 days.  Cells were passaged every 7-10 
days with fresh media and bFGF.  All cell culture reagents were from Sigma-Aldrich (St. 




Traumatic brain injury model 
Controlled Cortical Impact Injury 
Unilateral contusions were generated using a custom-built controlled cortical impactor 
(CCI) device as described previously (Dixon et al. 1991; Tate et al. 2001).  Adult male 
C57BL6 mice (8-12 weeks old; Jackson Laboratory, Bar Harbor, MN) were anesthetized 
with isoflurane (induction 3%; maintenance 1-2%) and placed in a stereotaxic frame.  
The skull was exposed and a tissue-punch craniotomy (4 mm diameter) was preformed 
on the exposed skull over the left frontoparietal cortex (center: 2.0 mm posterior to 
bregma; 2.0 mm lateral to the midline).  The impactor rod was angled perpendicular to 
the tangential plane of the brain surface (15º from vertical).  The injury was delivered in a 
controlled manner by a pneumatically-operated metal impactor (3 mm diameter) at a 
velocity of 6.0 m/s to a depth of 1.0 mm below the dura mater for a duration of 150 ms.  
A linear variable displacement transducer (LVDT) connected to the impactor recorded 
velocity and duration to verify consistency among the injuries.  Following injury, the 
incision was sutured and animals were allowed to recover on warm pads.  Sham 
surgeries for uninjured controls involved anesthesia, incision, crainectomy, and suturing. 
The mechanical impact leads to cell death in the impacted area and surrounding tissue.  
A cavity forms at the impact site by one week post-CCI.  All mice were housed in a 
temperature and humidity-controlled environment with a 12:12 hour light:dark cycle with 
food and water available ad libitum.   
 
All procedures conformed to guidelines set forth by the Guide for the Care and Use of 
Laboratory Animals and were approved by the Georgia Tech Institutional Animal Care 
and Use Committee (IACUC). 
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Transplantation of Stem Cells 
Seven days following the CCI injury, animals were anesthetized with isoflurane (3% 
induction, 1% maintenance) and placed in a sterotaxic frame.  The incision site for injury 
or sham was re-opened and MSCs (passage 5) or NSCs (passage 3) (6.125 x 104 cells 
in 7µL HBSS; 8.75 x 103 cell/µL) were transplanted through a Hamilton syringe  with a 
27-guage needle (Hamilton, Reno, NV) into the injury cavity.  Transplants were delivered 
into the center of the 4 mm crainiectomy circle at a 1.1 mm depth below the dura mater 
over 10 minutes (given at a constant rate of  >1µL/min using a syringe pump (Sage 
Instruments) to press the piston of the Hamilton syringe).  After injection, the needle was 
left in place for an additional 5 minutes and then withdrawn slowly over 2 minutes to 
minimize leakage through the needle track.  Incisions were sutured and animals were 
kept on a heating pad for recovery.  Vehicle control animals received 7 µL HBSS without 
cells.  Animals receiving the sham surgery (injured controls, sham, and naïve animals) 
were anesthetized and the incision was re-opened and sutured, but no transplant or 
vehicle injection was given.  Groups for transplant were as follows: MSCs + vehicle 
(n=8), MSCs + scaffold (n=9), NSCs + vehicle (n=6), NSCs + scaffold (n=8), vehicle only 
(n=3), scaffold only (n=8), injured controls (no transplant; n=5), shams (no injury or 
transplant; n=4), naïve (anesthesia and suturing only; n=3). 
 
Behavioral Analysis 
Beam Walk Motor Functional Test 
The beam walk task was used as a measure of motor ability.  A narrow beam was used 
to measure fine motor coordination as described previously (Fox et al. 1998).  Mice were 
trained one week prior to injury surgery and were tested for baseline levels one day prior 
to injury surgery.  The mice were placed at the start point near the end of a narrow beam 
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(12 mm width for the first 50 cm; 6 mm width for the second 50 cm; 25 cm above a 
padded surface) and were allowed to traverse the beam into a darkened goal box.  The 
CCI injury to the left frontoparietal cortex results in deficits in motor control for the right 
hindlimb, so the outcome measure was the percentage of right hindlimb steps where the 
foot slipped 5 mm or more below the beam surface.  Mice were given three trials per 
time point, and the mean value was used in data analysis.  Mice were allowed to rest for 
30 seconds in the goal box between trails for both training and testing.  Testing occurred 
at 1 day prior to CCI-injury, at 6 days post-injury (1 day prior to transplant), and weekly 
until 8 weeks post-transplant.  All researchers involved in the beam walk data collection 
and analysis were blinded. 
 
Statistical Analysis 
Data were analyzed by parametric analysis of variance (ANOVA) followed by Tukey’s 
pairwise comparisons (p<0.05).  Means were considered to be statistically significant by 
using an alpha value of 0.05.  Data is reported as mean ± standard deviation.  A post-
hoc power analysis was calculated to determine the minimal number of subjects needed 
to have 80% power (α = 0.05, β = 0.2; assuming 100% prevalence) at detecting a 15 - 
30% improvement effect. 
 
Histological Analysis 
Tissue Harvest and Processing 
Animals were sacrificed at 8 weeks post-transplant for histological analysis.  Mice were 
anesthetized with an intraperitoneal injection of pentobarbital (80 mg/kg) and were 
perfused with PBS (0.1M; pH 7.4) followed by 4% paraformaldehyde in PBS.  Brains 
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were harvested, post-fixed (4% paraformaldehyde; 4°C; 12 hours), and cryoprotected 
(phosphate-buffered 30% sucrose).  Then, brains were embedded in optimal cutting 
temperature (OCT) medium (Sakura, Torrence, CA), frozen, and stored at -80°C.  Brains 
were cut into 10 µm thick coronal sections on a Microtome Cyrostat (Richard-Allan 




Serial sections were stained for Nissl with cresyl violet (0.5%; pH 2.5; Sigma-Aldrich, St. 
Louis, MO).  Briefly, slides were dipped successively in acetone (5 minutes), air dried (5 
minutes), dipped in dH2O (1 minute), stained in cresyl violet (3 minutes), dipped in 95% 
ethanol twice (10 seconds each), dipped in 100% ethanol three times (30 seconds, 1 
minute, and 2 minutes respectively), dipped in xylene twice (2 minutes each), and 
coverslipped with Permount.  The Cavalieri volume estimator (Rosen and Harry 1990) 
with Stereo Investigator software (Microbrightfield Bioscience, Williston, VT) was used to 
determine the volume of the injury cavity (sections at 80 µm increments per brain). 
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2.3 Results   
Cortical Contusion Impact Produces a Deficit  
Motor behavior was assessed weekly for eight weeks post-transplant using the beam 
walk task.  The CCI-injury to the frontoparietal cortex resulted in an injury deficit 
throughout the testing period for all injury groups compared to sham or naïve control 
groups for both the 6 mm (Figure 2.2) and the 12 mm (Figure 2.3) beam walk tasks 
(two-way ANOVA, n=6-10; p<0.05).  There was no statistical difference between sham 







Figure 2.2: Behavioral assessment of motor coordination on the 6 mm beam walk 
following cortical contusion injury and transplant.  There was a significant injury 
deficit in all injured groups compared to sham and naïve animals, however, no statistical 









Figure 2.3: Behavioral assessment of motor coordination on the 12 mm beam walk 
following cortical contusion injury and transplant.  There was a significant injury deficit in 
all injured groups compared to sham and naïve animals for weeks 1, 2, 3, and 5 post-
transplant. (Two-way ANOVA, n=6-10; p<0.05). 
 
 24 
 At the 8 week time point for the 6 mm beam walk task (Figure 2.4), there is still a 
statistical difference between the sham/naïve group and all groups which received a CCI 
injury.  Certain individual animals showed some functional recovery within the treatment 
groups including the MSC and MSC+scaffold groups, however, there was no statistical 
difference.  
 
In the 12 mm beam walk task, the mice had spontaneously recovered by 8 weeks to the 
point where there was no longer a difference between the injured groups and the 
sham/naïve group (Figure 2.5).  However, there was considerable variability in the 
individual animal outcomes. The difference between the 6 mm and 12 mm deficits 
suggests that the 12 mm beam walk task may not be sensitive enough to detect 
lingering injury deficits at 8 weeks since injured mice still have significant deficits with the 








Figure 2.4: Behavioral assessment of motor coordination on the 6 mm beam walk 
at 8 weeks post-transplant.  There was a significant injury deficit in all injured groups 
compared to sham and naïve animals (* significant difference verses sham/naïve group; 
p>0.05).  While there are no statistical differences between treatment groups and injured 
controls, some individual animals showed improvement; however, there was 












Figure 2.5: Behavioral assessment of motor coordination on the 12 mm beam walk at 8 
weeks post-transplant.  There is no statistical difference in the injured groups and the 
sham/naïve group suggesting that this test may not be sensitive enough to detect 
lingering injury deficits at this late time point since injured mice still have significant 
deficits with the 6 mm beam walk task. 
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Post-hoc power analysis 
6 mm beam walk task 
A post-hoc power analysis was performed on the beam walk task to determine sample 
size that would have been needed to observe a difference using the means and 
standard deviations in this study using the same two-way ANOVA statistical analysis.  
For the 6 mm beam walk task, assuming a confidence interval of 95% and a power of 
0.80, a sample size of 12 animals per group would have been required to observe a 
difference of 20% improvement in foot falls and a sample size of 22 animals per group 
would have been required to detect a 30% improvement in foot falls.    
 
12 mm beam walk task 
On the 12 mm beam walk task, the difference observed between the sham/naïve group 
and the injured control at 8 weeks was 15% difference in footfalls.  Using this as the 
effect and the largest standard deviation of any treatment group, a sample size of 53 
would have been required to detect a difference.  Since animal transplant studies 
requiring more than 400 subjects (8 groups) are not practical, this suggests that this 
motor function task is not sensitive enough at 8 weeks and that another motor task 
should be used. 
 
Mesenchymal stem cells may result in a smaller injury cavity 
The lesion volume resulting form the CCI injury and MSC or NSC transplants was 
calculated by Stereo Investigator from Nissl-stained brain sections at 8 weeks post-
transplant.  The average lesion volume for brains transplanted with MSCs was 3.85 ± 
0.05 mm3 (n=2) while the lesion volume for NSC transplantation was 4.60 mm3 
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(n=1)(Figure 2.6).  While the small number of samples did not allow for statistical 
analysis, there is a trend that the brains receiving MSCs had less brain tissue lost than 
the brain receiving NSCs.  For comparison from a previous study, injured brains which 
did not receive a treatment had a lesion volume of ~8 mm while treatment groups had 
similar reduction as seen with the NSCs and MSCs (Tate, C, unpublished results).  This 







Figure 2.6: Lesion volume of traumatically injured brains transplanted with either 
NSCs or MSCs at 8 weeks post-transplant. Average lesion volume for brains 
transplanted with MSCs was 3.85 ± 0.05 mm3 (n=2) while the lesion volume for NSC 




Transplantation of stem cells following TBI is a potential treatment option, however both 
the source of donor cells and delivery parameters need to be studied in a controlled 
manner.  Here we present a transplantation study comparing NSCs and bone-marrow 
MSCs transplanted with a laminin-containing scaffold or vehicle.  Behavioral analysis of 
motor coordination by the 6mm beam walk task showed a significant injury deficit in 
injured groups compared to naïve or sham groups, however the effects of the 
transplants are inconclusive.  We also present preliminary data on lesion volume in 
which transplants of MSCs yield a smaller lesion then after a NSC transplant. 
 
Transplantation of MSCs showed a trend of decreasing motor deficits although at a level 
that was not statistically significant.  The level at which the MSCs decreased the motor 
deficit was comparable to the level of the NSCs.  In addition, transplantation within the 
scaffold appeared to further enhance the effect of either the cells or the scaffold alone in 
both MSCs and NSCs. 
 
While behavioral recovery is the optimal assessment of a treatment, there are several 
inherent limitations of behavioral tests that can lead to inconsistent and inconclusive 
results.  While past experiments in our laboratory of transplanted NSCs have shown 
behavioral recovery with the beam walk task at 8 weeks (Tate, unpublished results), it is 
possible that the duration of testing did not extend long enough to show statistically 
significant results or that another motor task (potentially involving a more complicated 
task) may have shown motor recovery sooner.  
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In addition, this study involved fewer transplanted cells than some of the previous 
studies, adding to the possibility that they may have required a longer time frame to 
show effects or that the number of cells given was below the effective dose.  There has 
also been a correlation between the number of surviving cells within the brain and 
functional recovery (Tate, unpublished observations); however since the MSCs 
decreased their GFP+ expression significantly following transplantation, there was 
difficulty in distinguishing donor cells from host, so the correlation of donor cell survival 
to functional recovery could not be completed.  Alternately, it may be possible to 
correlate the number of degenerating neurons as identified with Fluoro-Jade staining to 
the behavioral results (currently under quantification). 
 
From the post-hoc power analysis, future studies should increase the sample size to at 
least 12 subjects per group for the 6 mm beam walk task.  In addition, another more 
sensitive task should be considered in place of the 12 mm beam walk task.  
Furthermore, attempts should be made to decrease variability as this study had higher 
variability than is usually observed.  There are many sources of variability within 
behavioral outcome studies in animal models and clinical trials (Watts and Dunnett 2000; 
Lindvall and Bjorklund 2004).  While patient-to-patient variability certainly plays a role, 
variability of the donor cells may contribute in large part.  MSCs are a small proportion of 
the bone marrow from which they are harvested and isolation protocols can yield 
anywhere from a fairly pure population of stem cells to a heterogeneous mix.  One 
potential area to decrease variability is to use a more stringent isolation method and 




In addition, since the extracellular context influences cell survival and differentiation, 
priming the cells either prior to transplant or with a delivery scaffold may increase their 
effect on host recovery.  Priming the cells in vitro may include incubating them with 
growth factors, growing them on extracellular matrix proteins, or exposing them to 
mechanical forces.  Transplanting cellular aggregates would allow cells to be 
transplanted at greater densities in the cavity and may increase cell survival by 
influencing intercellular signaling through cell-cell interactions.  Another mechanism to 
potentially increase cell survival and decrease variability is to inject cells within a scaffold 
to which they can adhere and migrate.  Mice transplanted with MSCs injected within the 
laminin-containing scaffold had fewer footfalls on average than those transplanted with 
MSCs in a saline vehicle.  Although the results are not statistically significant, it was a 
fairly consistent trend across the 8 weeks.  However, a scaffold that was designed for 
NSCs may not be the most suitable scaffold for the transplantation of MSCs, so it may 
be helpful to examine other potential scaffold constituents such as fibronectin or 
collagen. 
 
Although the data for this behavioral study are inconclusive with respect to the efficacy 
of MSCs as a treatment for brain injury, there are prior reports of beneficial MSC 
transplantation (Lu et al. 2001; Mahmood et al. 2004; Mahmood et al. 2006) and the 
presence of MSCs do not appear to be detrimental to endogenous recovery 
mechanisms.  In addition, the decrease in lesion volume observed with MSCs is 
encouraging.  Therefore, there remains potential for MSCs to be used as a donor cell 
source for transplantation.  However, it will be important to find a method to refine MSC 
culture methods and to characterize the cells prior to transplantation.  It may also be 
potentially beneficial to prime the cells prior to transplantation and/or find an appropriate 
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Animal experiments were performed with Sarah Stabenfeldt.  Sarah Stabenfeldt also 
provided the NSCs and laminin-containing scaffold.  Vishnu Ambur and Morgan Wolfe 
provided assistance with tissue sectioning.  Scott Medway assisted in Nissl and Fluoro-
Jade staining and with Stereo Investigator.  Previous work by Matt Tate and Ciara Tate 




EXTRACELLULAR INFLUENCES ON BONE MARROW-DERIVED  
MESENCHYMAL STEM CELL-SPHERES 
 
3.1 Introduction 
Within the bone marrow there are many cell types including hematopoetic stem cells 
which are responsible for repopulating the blood and mesenchymal stem cells (MSCs).  
MSCs are non-hematopoetic stem-like cells capable of differentiating into multiple cell 
types of mesenchymal and non-mesenchymal origin (Prockop 1997; Mezey et al. 2000; 
Herzog et al. 2003).  While there is not a single marker to identify MSCs, they are 
generally defined by a combination of physical, phenotypic, and functional properties 
including the lack of hematopoetic markers and ability to differentiate into osteoblasts 
and adipocytes.  While there are multiple similar definitions of MSCs and related cell 
types isolated from the bone marrow, this is one we will use here.   
 
Bone-marrow derived mesenchymal stem cells have been shown to be capable of self-
proliferation and differentiation into multiple types including neural progenitor cells 
(Prockop 1997; Mezey et al. 2000; Jiang et al. 2002a; Herzog et al. 2003; Verfaillie et al. 
2003).  Transplantation of MSCs has shown some promise for treatment in animal 
models of stroke, traumatic brain injury, spinal cord injury, and neurodegenerative 
diseases (for review see (Corti et al. 2003; Dezawa 2006; Tang et al. 2007)).  However, 
in clinical trials there has been difficulty in determining the effectiveness of stem cell 
transplants in part due to the high variability of outcomes.  One source of variability 
within these studies is the composition and properties of the donor cells. 
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MSCs are low in abundance within the heterogeneous bone marrow especially in the 
adult, therefore during stem cell culture, it is important to find methods by which to 
isolate and expand the stem cells from other interfering cell types.  In addition, methods 
for MSC isolation are not standardized, and therefore, it is difficult to draw conclusion 
among multiple investigators when the starting material may vary greatly depending on 
the culture protocol. 
 
In the context of transplantation into the brain, priming MSCs towards a neuroprogenitor 
lineage in vitro prior to transplantation may improve transplant survival and efficacy.  
Neural stem cells (NSCs), which can differentiate into neurons, astrocytes, and 
oligodendrocytes, are cultured as floating clonal colonies in a defined, serum-free 
medium.  NSCs isolated from the subventricular region of the brain are FGF-responsive 
and/or EGF-responsive depending in part on the age of harvest (Ciccolini and Svendsen 
1998; Ciccolini 2001).  NSCs express the neuroprogenitor marker, nestin, but do not 
express mature neural markers such as NeuN, GFAP, or NG2 until growth factors are 
withdrawn.  Many investigators have described in vitro neural induction methods for 
MSCs, however, induction protocols vary widely, are sometimes contradictory, and only 
a few produce cell aggregates which resemble neurospheres (Lu et al. 2002; Hermann 
et al. 2004). 
 
Cell aggregates or spheres may have several advantages for transplantation. Spheres of 
cells are densely-packed allowing the transplantation of high numbers of cells in a small 
volume.  In addition, cells in spheres may be expressing increased cell-cell and cell-
matrix receptors which may influence migration once the cells have been delivered.  Cell 
aggregates for transplantation are ideally fast growing, homogeneous in size, 
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reproducible, viable throughout the interior, and sized to an overall diameter that can 
easily be injected through a Hamilton syringe. 
 
Transplantation of tissue-engineered constructs consisting of multipotential stem cells 
and a bioactive extracellular matrix (ECM)-based scaffold may increase graft survival 
and migration. However, an optimal scaffold preparation has not yet been fully 
established for transplantation of MSCs into the brain. Determining the interactions of 
donor cells with ECM proteins (including adhesion, migration, and additional ECM 
production) will help evaluate and predict appropriate scaffold components 
 
Here we present a novel method to induce murine bone marrow-derived mesenchymal 
stem cells (MSCs) to form highly homogeneous nestin-positive spheres which can be 
produced in multiple diameters depending on culture conditions.  We also begin to 
explore the interaction of the MSC-spheres with the ECM and changes to the MSCs 
which occur during or following sphere formation. 
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3.2 Methods 
Harvest and Isolation of MSCs 
Low Density Method 
MSCs were isolated and harvested as described before (Peister et al. 2004) with slight 
modifications.  Whole bone marrow was isolated from the femurs and tibias of 8-10 week 
old male GFP+ transgenic C57BL/6-Tg(cAG-EGFP)C14-701-FM131Osb mice (C57BL6 
background) mice bred in house.  Mice were sacrificed, and bones were dissected out 
and cleaned of muscle and connective tissue.  One end of the bone was clipped and the 
bone marrow extracted by centrifugation in modified microcentrifuge tubes.  The pellet 
from each bone was re-suspended in Cell Isolation Media (CIM; RPMI-1640, 10% FBS, 
and 10% Horse Serum), mechanically-dissociated by a 22-gauge needle, filtered 
through a 70 µm filter, and plated in a T175 flask.  At 24 hours, non-adherent cells were 
removed, cells were rinsed with saline, and fresh CIM was added.  Cells were fed every 
3-4 days. After 4 weeks, cells were trypsinized for 2 minutes and re-plated in CIM in a 
T175 flask. Cells that did not detach in 2 minutes were discarded.  After 2 weeks, cells 
were trypsinized for 2 minutes and re-plated in 100 mm tissue culture dishes at a density 
of 50-500 cells/cm2 in Cell Expansion Media (CEM; IMDM, 10% FBS, and 10% Horse 
Serum).  Once passage 3 cells were confluent, they were either expanded further in 100 
mm dishes or frozen (FBS + 10%DMSO).  Cells were used between passages 4-10. 
 
Plastic Adherence Method 
Bone marrow was removed as described above. Bone marrow from a single bone was 
re-suspended in 3mL DMEM + 20% FBS and placed in a 6 well plate.  Non-adherent 
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cells were removed at 24 hours and cells were expanded into T75 flasks based on 
confluency.  Cells were used between passages 3-5. 
 
Adipogenesis and Osteogenesis of MSCs 
Cells were plated in 100 mm tissue culture dishes with CEM for 10 days and then 
switched into adipogenic induction media (AIM; IMDM, 10% FBS, 10% HS, 12 mM L-
glutamine, 5 µg/mL insulin, 50 µM indomethacin, 1x10-6 M dexamethasone, 0.5 µM 3-
isobutyl-1-methylxanthine, and 100 U/mL penicillin/streptomycin) or osteogenic induction 
media (OIM; IMDM, 10% FBS, 10% HS, 12 mM L-glutamine, 20 µM β-glycerol 
phosphate, 50 ng/mL thyroxine, 1 nM dexamethasone, 0.5 µM ascorbate-2-phosphate, 
and 100 U/mL penicillin/streptomycin) for 2-3 weeks (media was changed every 3-4 
days.)  Cells were fixed with 10% formalin for 20 minutes at room temperature and then 
either 0.5% Oil Red O (Sigma) in methanol or Alizarin Red S (Sigma) for 20 minutes at 
room temperature and visualized on a Nikon TE300. 
 
Cell Surface Marker Analysis 
Low density method MSCs (passage >3), plastic adherence method MSCs, and freshly-
isolated whole bone marrow (from a littermate or closely related mouse of the same age) 
were incubated with the following antibodies to CD45-PE (Becton Dickinson 553081; 
leukocyte common antigen, Ly-5) and CD11b-APC/Cy7 (BD 557657; macrophage and 
granulocyte marker, Mac-1, Integrin αM chain) for 20 minutes at room temperature in the 
dark.  Cells were analyzed by flow cytometry on a Becton Dickinson LSR Flow 




MSCs were expanded to 80-90% confluency in 100 mm tissue culture dishes.  Cells 
were trypsinized, and plated in NeuroBasal A (Invitrogen, Carlsbad, CA) supplemented 
with serum substitute B27 (Invitrogen), insulin (25 µg/mL), transferrin (100 µg/mL), 
putrescine (60 µM), sodium selenite (30 nM), progesterone (20 nM), and L-glutamine in 
100 mm Petri dishes or tissue culture dishes.  Cell seeding density was 500,000-
750,000 cells/dish unless stated otherwise.  Cells were incubated on a rotary shaker at 
speeds of 0, 25, 40, or 55 rpm for up to 14 days.  Human recombinant basic growth 
factor (bFGF; 10 ng/mL; PreproTech) and/or EGF (10 mg/mL) was added to the media 
every 2-3 days. 
 
Sphere Size Determination 
MSC-spheres were induced and photographs were taken at specified timepoints on a 
Nikon TE300 microscope.  Using Image Pro Plus software, the circle tool (which draws a 
circle and calculates the area, circumference, and related parameters) was used to 
encircle each individual sphere in 10X and 20X images.  The software calculates the 
radius from the known magnification based on the pixels in the image which is a known 
quantity from the objective and imaging software used.  Data were exported to Excel and 
the average sphere radius for each condition and timepoint was calculated.  Data were 
averaged for at least 50 spheres per condition per timepoint for radius calculations.  
Data was imported to Igor (Wavemetrics), binned into even radius ranges, and graphed 
as histograms.  Outliers, which were defined as more than two standard deviations from 
the mean, were excluded.  Standard error of mean (SEM) and/or standard deviations 
were calculated where appropriate, and two-tailed, paired Students t-test was used to 




MTT Viability Assay 
Viability was quantified by the MTT Assay Kit (Sigma) according to the manufacturer’s 
instructions.  MTT is a reagent that is cleaved by the mitochondria of active cells forming 
insoluble purple crystals.  Briefly, cells were incubated with MTT solution for 2-4 hours at 
37°C in an incubator.  MTT solublization solution was added and the plate was rocked 
and/or triturated to dissolve formed crystals.  Absorbance was taken at 570nm/690nm.  
Results were averaged for 4-6 wells per condition.  Average absorbance was corrected 
for the number of spheres per well.   
 
Live/Dead Staining 
Viability throughout the spheres was examined by Live/Dead staining of representative 
spheres with Calcein Blue (live cells) and ethidium homodimer (dead cells) and imaged 
on a Zeiss LSM 510 Confocal Microscope for 3-color channels.  Ethanol-treated positive 




Cells were fixed in suspension with ethanol and glacial acetic acid for 20 minutes.  Cells 
were suspended in Histogel and paraffin embedded, and sectioned (7 µm) on a 
microtome.  Slides were deparaffinized, and antigen retrieval was preformed with 




Cells were permeablized with 0.3% Triton-X100 and 4% goat serum in PBS for 20 
minutes at room temperature.  Cultures were blocked with 4% goat serum.  Primary 
antibodies were incubated overnight at 4º C against the following proteins: Nestin Rat-
401 (Chemicon MAB353; 1:200), fibronectin (Chemicon AB5032; 1:200), integrin α5β1 
(Chemicon MAB2514; 1:100), neurocan (MAB 5212; 1:500), L1 (Chemicon MAB5272; 
1:200), GFAP (Chem MAB360; 1:200), N-cadherin (Zymed 33-3900; 1:200), vimentin 
(Chem MAB3400; 1:300), integrin αv (Chemicon AB1930; 1:1000), CD-44 (Zymed 13-
5500; 1:300), O4 (Chem MAB 345; 1:300), integrin β3 (Chem AB1932; 1:80), SSEA-1 
(Chem MAB353, 1:200), integrin β4 (Chem AB1922; 1:200), NeuN (Chem MAB377; 
1:200), NG2 (Chem AB5320; 1:300).  Spheres were counterstained with nuclear stain 
Hoechst 33258.  NSCs were used as a positive control from nestin, fibronectin, laminin, 
GFAP, and NG2 (data not shown).  For remaining stains, no positive control was found.  
Secondary-only controls were used to set imaging parameters.  Secondary anti-mouse-
Alexa 546 (1:500), anti-rabbit-Alexa 633 (1:500), and anti-rat IgG-FITC (1:200) 




Adherent MSCs (MSC-LD) were grown for 3 days on coverslips.  MSC-spheres were 
grown for 14 days as described above.  Cells were rinsed with PBS, and fixed in 3.7% 
formalin for 15 minutes at room temperature.  Cells were then rinsed with PBS and 
permeabilized with 0.1% Triton-X-100 in PBS for 15 minutes at room temperature.   
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Cells were stained with Hoechst 33258 (25 µg/mL) and phalloidin-Texas Red (2U/mL) 
for 20 minutes at room temperature in the dark.  Cells were rinsed twice for 15 minutes 
in PBS and mounted on slides in Gel Mount. 
 
Radial Migration Assay 
Tissue culture treated plates (24-well) were incubated with known concentrations of 
extracellular matrix proteins overnight.  Protein solution was removed, and MSC-spheres 
were seeded in the wells and incubated at 37°C.  MSC-spheres were then photographed 
on a Nikon TE300 and the radial migration distance was measured.  To measure 
migration, a circle was drawn to the edge of the sphere and eight radiating lines were 
drawn at 45° angles around the circle.  Migration in that direction was measured as the 
farthest distance a cell has traveled along that line.  Migration distances along the eight 
lines were averaged for a given sphere.  At least 6-10 spheres were measured for each 
condition and results were averaged. 
 
Data Analysis 
Data were exported to Excel (Microsoft) or Igor Pro (Wavemetrics), and average sphere 
radius was calculated.  Averages of sphere radii represent at least 50 sample spheres 
per condition.  Outliers that were greater then two standard deviations from the mean 
were excluded.  Standard error of mean (SEM) and/or standard deviations were 





Figure 3.1: MSC harvest, isolation, expansion, and induction methods. 
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3.3 Results 
Low density isolation produces more consistent MSC cultures 
MSCs isolated from the low density method described by Peister, et al. (Peister et al. 
2004) (MSCs-LD) differed from MSCs isolated by the traditional plastic adherence 
method (MSCs-PA) based on several criteria.  By passage 3, MSCs-LD were a less 
heterogeneous population of large (~15 µm diameter) cells with prominent nuclei 
(Figure 3.2A).  MSC-PA were in general smaller (6-10 µm diameter) and were a 
heterogeneous population ranging from small spindle shaped-cells to large flattened 
cells (Figure 3.2B). 
 
Low density isolation selects multipotential cells 
MSCs-LD and MSCs-PA were analyzed for their ability to differentiate into adipocytes 
and osteoblasts through phenotypic-specific induction media.  MSCs were seeded into 
6-well plates with adipogenic or osteogenic induction media for 2 weeks and 3 weeks 
respectively.  Cells were then fixed and stained with Oil Red O for lipids or Alizarin Red 
S for calcium phosphate deposits.  Representative pictures of cultures show 
approximately 90% of MSCs-LD in adipogenic media stained positive with Oil Red O 
(Figure 3.2C).  On the other hand, only about 10% of MSC-PA in adipogenic media 
stained positive with Oil Red O (Figure 3.2D).  In osteogenic media, approximately 50% 
of MSC-LD had some staining with Alizarin Red (Figure 3.2E) and approximately 20% of 
MSCs-PA had a similar level of staining (Figure 3.2F).  Although the staining was lighter 
than typically observed with osteoblasts, the cells had some positive areas suggesting 
the cells were in early stages of differentiation which is consistent with observations that 
MSCs isolated from C57BL6 mice take longer to differentiate into osteoblasts ((Peister et 
 45 
al. 2004) and personal communication with Alex Peister).  MSCs-LD and MSCs-PA 
incubated in non-inductive expansion media had less than 5% positive cells for either Oil 






Figure 3.2: Morphology and differentiation potential of MSCs isolated by the low-
density method and plastic adherence methods. Phase contrast images of A) MSC-
LD and B) MSC-PA.  MSC-LD cells are more homogeneous in size and morphology 
than MSC-PA.  Differentiation potential of MSC-LD and MSC-PA. C) MSC-LD and D) 
MSC-PA cultured in adipogenic induction media and stained with Oil Red O. E) MSC-LD 






Low density isolation selects non-hematopoetic cells 
MSCs-LD, MSCs-PA, and whole bone marrow from congenic mice were analyzed by 
flow cytometry for cell surface marker CD45 (PE) which is found on hematopoetic cells 
including leukocytes and CD11b (APC-Cy7) which is expressed by macrophages, 
microglia, and activated neutrophils.  Nearly all cells within the whole bone marrow 
expressed high levels of CD45 and a portion of cells was high for both CD45 and CD11b 
(Figure 3.3A).  MSC-PA had a different profile with a population expressing low levels of 
both CD45 and CD11b and a population with high levels of both (Figure 3.3B). The 
majority of MSCs-LD had lower level of CD45 than either bone marrow or MSC-PA and 
only a few which were medium-high for CD11b (Figure 3.3C).  Noticeably absent in the 
MSC-LD group was the population of high CD45 and high CD11b cells. Cells were gated 
based on size to exclude red blood cells and small debris. 
 
Together these results suggest that MSC-LD have a higher percentage of cells than 
MSCs-PA which fit the criteria traditionally used to define MSCs (multipotential and low 
expression of CD45 and CD11b), and therefore may be a more homogeneous 
population of stem cells.  Unless stated otherwise, MSCs-LD were used in all 
























































Figure 3.3: MSC cell surface marker expression.  A) Whole bone marrow, B) MSC-
PA, and C) MSC-LD were incubated with CD45-PE (y-axis) and CD11b-APC-Cy7 (x-
axis) antibodies.  Expression levels were measured by flow cytometry.  Noticeably 
absent in the MSC-LD sample is the population with high levels of both CD45 and 
CD11b. Cells were gated to exclude red blood cells and small debris. (n=5 per condition) 
 
A) B) C) 
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MSCs can be induced to form multicellular spheres 
MSCs isolated by the low density method (passage 3-8) were induced to form spherical 
cell aggregations by seeding them in sphere induction media in 100 mm non-tissue 
culture treated Petri dishes on rotary shaker in an incubator at speeds of 0, 25, 40, or 
55rpm or in 100 mm tissue culture treated dishes.  Cells were supplemented with bFGF 
(10 ng/mL) every 2-3 days.  By this method, MSCs formed mutlicellular aggregates 
(MSC-spheres) within one week (Figure 3.4).  Other media formulations or growth factor 
additions did not induce sphere formation (see Appendix A).  MSCs isolated by the 








Figure 3.4: MSCs form multicellular aggregates following 
induction.  Scanning electron micrograph of MSC-sphere 7 days 
post-induction on 40 rpm rotary shaker.  MSCs were seeded at 
75,000 cells/mL in induction media supplemented with bFGF and 
EGF every 2-3 days.  Interior of grid is 55 µm square. 
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MSC-sphere radius is dependent on rotary speed 
On tissue culture treated dishes, MSCs first adhered to the bottom of the dish, and then 
after 2-3 days aggregated into small clumps of cells which formed raised, rounded, 
conglomerates of cells.  After 7-10 days, a subset of these spheres detached from the 
surface and floated in the media.  Sphere size was highly variable as was the shape with 
most appearing more oval than round. Static cultures in Petri dishes (non-tissue culture 
treated) formed spheres of variable size similar to those in the tissue culture treated 
dishes, but they also had a smaller portion of cells attaching to the bottom. Conversely, 
on the rotary shakers, within 24 hours, MSCs were forming multicellular aggregations 
(MSC-spheres).  With rotary motion, spheres were more consistent in size and shape. 
 
The size of MSC-spheres was dependent on rotary speed.  MSCs were induced on 
rotary shakers at speeds of 0 rpm, 25 rpm, 40 rpm, and 55 rpm with a seeding density of 
75,000 cells/mL.  At 7 days after induction, sphere size was measured. The average 
radius of spheres formed at 25 rpm was 70.5 ± 9.0 µm while the average radius formed 
at 40 rpm was 36.0 ± 4.8 µm.  MSC-spheres formed at 55 rpm had a radius of 11.7 ± 
3.87 µm. The static (0 rpm) culture yielded spheres that were 12.7 ± 5.0 µm.  In Figure 
3.5 the distribution of sphere radii for the different speeds is plotted as a histogram with 







Figure 3.5: MSC-sphere size is dependent on rotary speed during induction.  Induction 
rotary speed of A) 0 rpm, B) 25 rpm, C) 40 rpm, and D) 55 rpm produced significantly different 
sized spheres. All MSCs were seeded at 50,000 cells/mL with bFGF and measured at 7 days 
post-induction. n ≥ 50 spheres/speed. 
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MSC-sphere radius is dependent on cell seeding density. 
MSC-sphere size is also dependent on seeding density.  MSCs were seeded at 10,000 
cells/mL, 50,000 cells/mL, 100,000 cells/mL, and 200,000 cells/mL and incubated on the 
40 rpm rotary shaker.  At 4 days, spheres from the 10,000 cells/mL dish had an average 
radius of 8.8 ± 1.3 µm (n=32) while spheres from the 50,000 cells/mL dish had an 
average radius of 13.1 ± 2.2 µm (n=49).  Seeding the plate at 100,000 cells/mL and 
200,000 cells/mL produced spheres with an average radius of 31.3 ± 7.2 µm and 18.3 ± 
5.4 µm respectively.  However, spheres with 200,000 cells/mL had formed several 
clumps of spheres (several of which exceeded 500 µm) which were excluded from the 
measurements since they were too large to capture even in the 4X objective.  Also 
because of the clumping, there was a large variation in size in the 200,000 cells/mL 
group. Figure 3.6 presents a histogram of the sphere radii by seeding density and 
representative photos of each.  Spheres in the 100,000 cells/mL and 50,000 cells/mL 
groups produced spheres with a radius of 30-50 µm at 7 days (data not shown) with the 
most consistent sized spheres.  Therefore, MSC-spheres were chosen to be produced 
on the 40 rpm rotary shaker at a seeding density of 75,000 cells/mL for future studies.   
 
MSC-spheres are viable though the sphere interior 
To verify that the interior of the spheres were not necrotic, a Live/Dead assay was 
performed with Calcein Blue which fluoresces blue in living cells and ethidium 
homodimer which stains dead cells red.  The spheres were then imaged on a confocal 
microscope.  Although sphere size differed with rotary speed, dead cells were not 
observed in the center of the spheres at any sphere except the ethanol-treated control.  







Figure 3.6: MSC sphere radius is determined by the seeding density. MSCs were seeded at A) 
200,000 cells/mL, B) 100,000 cells/mL, C) 50,000 cells/mL, and D) 10,000 cells/mL at 40 rpm with 
bFGF.  After 4 days, the spheres had noticeable size differences.  
 
Sphere size is dependent on rotary speed.  Representative spheres at 7 days post-induction at 50,000 cells/mL.  All pictures are 20x. Scale bars =20 µm.  
Static 25 rpm 40 rpm 55 rpm 






   
Figure 3.7: Viability of MSC-spheres. A) Static Tissue Culture B) 40 rpm C) ethanol-
treated control MSC-spheres were stained with calcein blue (live cells) while ethidium 
homodimer (red; dead cells) and viewed on a confocal microscope.  
 
A) B) C) 
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MSC-spheres are bFGF and EGF responsive 
Formation of MSC-spheres is dependent on growth factor addition 
Sphere formation was dependent on the presence of bFGF in the induction media.  
Spheres did not form if bFGF was not added during the first day of induction, however, 
the maintenance of spheres was less sensitive to additional supplements of bFGF added 
between 2-5 days without obvious differences in the timing (data not shown). Although, 
the addition of EGF influenced sphere size and viability (data below), EGF was not 
sufficient for sphere formation in the absence of bFGF (data not shown). 
 
Growth factor addition influences sphere size and viability 
The addition of EGF during MSC-sphere induction increased both the average sphere 
radius at 7 days and the viability measured by the MTT assay.  The average radius of 
the spheres without EGF was 21.8 ± 6.5 µm while the average radius with EGF was 35.2 
± 7.8 µm (Figure 3.8A).  The cleavage of the tetrazolium ring of MTT is a measure of the 
mitochondrial activity in living cells.  The average reduction of MTT normalized per 
sphere was significantly increased 5.0 x 10-3 ± 0.7 x 10-3 (n=5 cultures) for the MSC-
spheres with bFGF and EGF compared to 4.0 x 10-3 ± 0.6 x 10-3 (n=5 cultures) for the 
MSC-spheres with only bFGF (t-test p=0.04) (Figure 3.8B). 
  
The cleavage of MTT is a measure of mitochondrial activity and not a direct measure of 
cell viability or cell number, however, taken with the live/dead staining and the larger 
sphere radius of the EGF supplemented spheres, it suggests that the spheres with EGF 
have more cells per sphere.  This was in agreement with our observations, however, 







Figure 3.8: Effect of EGF addition during sphere induction. A) Addition of EGF 
significantly increased the average sphere radius from 21.8 ± 6.5 µm to 35.2 ± 7.8 µm. 
B) Addition of EGF during induction significantly increased the reduction of MTT by 
formed MSC-spheres. The average reduction of MTT normalized per sphere was 5.0 x 
10-3 ± 0.7 x 10-3 for the MSC-spheres with bFGF and EGF and was 4.0 x 10-3 ± 0.6 x 10-3 
for the MSC-spheres with only bFGF. * t-test p-value ≤ 0.5 
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Growth rate of MSC-spheres is influenced by EGF 
MSC-spheres were induced at 75,000 cells/mL on tissue culture plastic, and at 25 rpm 
and 40 rpm on the rotary shaker with or without EGF. MSC-spheres were measured for 
their growth over two weeks post-induction.  The addition of EGF influenced the rate at 
which spheres began to form and hence their average size at 7 days, but did not affect 
their size at 14 days when growth had begun to plateau (Figure 3.9).  This effect was 







Figure 3.9: MSC-sphere size growth over two weeks with and without EGF. A) with 
bFGF and EGF (10 ng/mL) and B) bFGF alone without EGF ( 25 rpm,  40 rpm,  
Static Tissue Culture Plastic). The addition of EGF influenced the rate at which spheres 
began to form and hence their average size at 7 days, but did not affect their size at 14 
days when growth had begun to plateau.  All plates were seeded at 75,000 cells/mL. 
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MSC-spheres expression of neural markers 
MSC-spheres were stained fixed, paraffin embedded, sectioned, and stained by 
immunocytochemistry for neural markers and examined on a confocal microscope.  
MSC-spheres express neural precursor marker, nestin, but do not express significant 
amounts of GFAP, NG2, or NeuN.  This suggests that the MSC-spheres are remaining 







   
Figure 3.10: Expression of neural markers by MSC-spheres. MSC-spheres express 
A) nestin, but do not express significant amounts of B) GFAP, C) NG2, or NeuN (not 











MSC-spheres migrate on extracellular matrix proteins  
Migration is enhanced on laminin and collagen type IV 
MSC-spheres were plated in a 48-well plate that had been coated overnight with 
extracellular matrix proteins laminin-1, collagen type IV, and fibronectin at concentrations 
of 10 µg/mL and 5 µg/mL and on control wells for poly-L-lysine (10 µg/mL) and tissue 
culture plastic.  At 36 hours, the radial migration distance was measured.  Radial 
migration distance was significantly increased on all ECM proteins verses poly-L-lysine 
or tissue culture plastic (t-tests p<0.05). The migration of MSC-spheres is greatest on 
laminin-1 and collagen type IV (Figure 3.11).  In addition, fibronectin showed a 
concentration-dependent increase of migration distance while laminin and collagen type 
IV did not. 
 
Centrifugation of spheres increases migration 
Interestingly, it appears that centrifugation prior to plating for migration enhances 
migration distance (Figure 3.12) to the point that cells which have been centrifuged will 
migrate on laminin, collagen type IV, fibronectin, and tissue culture plastic equally (data 
not shown).  Differences in migration substrate were only significant when spheres were 
allowed to settle rather than being centrifuged.  Also interestingly, MSC-spheres migrate 
very little if plated in new MSC-S media, rather, they migrate to a much greater distance 
in conditioned media either from themselves, cultured astrocytes, or neural stem cells 






    
 
Figure 3.11: Migration of cells from MSC-spheres on extracellular matrix proteins. 
A) laminin, B) collagen type IV, C) fibronectin, and control D) poly-L-lysine.  E) Average 
radial migration distance for each condition.  Spheres migrated on laminin-1 and 
collagen type IV significantly more than fibronectin, poly-L-lysine, or tissue culture plastic 
( t-test; p-values <0.05).  In addition, there was a significant effect of coating 
concentration (5 µg/mL vs 10 µg/mL) for fibronection ( t-test; p-value <0.05).  Scale 















Figure 3.12: Migration of MSC-spheres is stimulated by centrifugation.  Prior to 
plating on tissue culture plastic, MSC-spheres were A) centrifuged at 1000 rpm for 3 
minutes or B) allowed to gravity settle in a 15 mL conical tube.  Spheres were plated 
with their own conditioned media.  Migration was photographed at 18 hours and 




MSC-spheres contain ECM proteins and cell adhesion receptors 
In addition to migrating on ECM proteins, MSC-spheres stained positive for ECM 
proteins within the sphere.  MSC-spheres were fixed, paraffin embedded, sectioned, and 
stained with immunocytochemistry for ECM proteins.  The MSC-spheres contained 
fibronection, laminin, vimentin, and neurocan, and to a lesser degree, they also stained 
positive for collagen IV (Figure 3.13).  In addition, we stained for cell-cell and cell-matrix 
adhesion molecules.  The MSC-spheres contained integrin α5β1, integrin αv, L1, and to 
a lesser degree N-cadherin and CD-44.  Therefore, the cells appear to be producing 
their own ECM and are expressing several cell-cell and cell-matrix adhesion markers.  




   
   
   
Figure 3.13: MSC-spheres stain positive for ECM proteins and cell adhesion 
proteins. A) Laminin B) Fibronectin C) Collagen IV D) Neurocan E) Vimentin F) Integrin 
α5β1 G) Integrin αv H) N-cadherin I) L1.  Immunostains are either red or green with 























































































MSC-spheres alter their cytoskeletal configuration 
Interestingly, although isolated from a GFP+ transgenic mouse under a β-actin promotor, 
MSCs have reduced GFP fluorescence as they are passaged compared to a fresh bone 
marrow isolation.  In addition, when they become MSC-spheres, the GFP fluorescence 
is even dimmer.  Therefore, we looked for the expression of β-actin in the spheres by 
staining for β-actin by immunocytochemistry in paraffin-embedded sections and by 
staining fixed cultures with phalliodin conjugated to Texas Red.  Prior to MSC-sphere 
induction, MSCs have obvious β-actin structure (Figure 3.14A) however they appear to 
decrease β-actin when in MSC-spheres (Figure 3.14B). 
 
To quantify these results, quantitative RT-PCR was performed for β-actin and 
normalized to GAPDH.  The MSC-spheres appear to have decreased production of β-
actin compared to the pre-sphere adherent MSCs (Figure 3.15).  Although surprising, 







Figure 3.14: MSC-spheres alter their cytoskeletal structure. A) MSCs in expansion 
culture and B) MSC-spheres were fixed and stained with phalliodin-Texas Red and 
counterstained with Hoescht.  In the sphere, MSCs decrease their cytoplasm and β-













Figure 3.15:  MSC-spheres significantly downregulate β-actin compared to the pre-
sphere MSCs. Quantitative RT-PCR for β-actin was performed and normalized to the 




MSC-sphere induction may alter gene expression 
During MSC-sphere induction, neurotrophins (brain-derived neurotrophic factor (BDNF), 
nerve growth factor (NGF), or neurotrophin-3 (NT-3)) were added every 2-3 days with 
bFGF and EGF and cultured on the 40 rpm rotary shaker.  MSCs were plated at 75,000 
cells/mL  One week after induction, RNA was isolated and quantitative RT-PCR was 
performed for Nanog and nestin.  Nanog expression was decreased in MSC-spheres 
compared to MSCs prior to sphere induction (Figure 3.16A).  The addition of 
neurotrophins during induction did not appear to alter this effect.  While there appears to 
be a trend in nanog expression, it is important to note that nanog expression in all cases 
is quite low in all samples.  The expression of nestin in MSC-spheres was enhanced by 
the addition of neurotrophins during induction (Figure 3.16B).  However, all adherent 





Figure 3.16: Expression of Nanog and nestin in MSC-spheres.  A) MSC-spheres 
have decreased nanog expression compared to MSCs prior to sphere induction.  The 
addition of neurotrophin does not appear to affect the expression further.  B) The 
addition of neurotrophins during MSC-sphere induction increases nestin expression in 







Bone marrow-derived mesenchymal stem cells have been shown to be a potentially 
useful source of donor cells for neurotransplantation; however high variability has been 
observed in donor cells which may influence transplant outcomes.  Therefore, a more 
defined population of cells to transplant may lead to more consistent results.  We have 
designed a novel method to yield multicellular MSC-spheres in reproducible sizes based 
on the culture parameters.  These MSC-spheres are bFGF and EGF-responsive and 
express nestin similar to neural stem cells.  They do not appear to express high levels of 
GFAP, NeuN, or NG2 in their MSC-sphere state.  In addition, they migrate on laminin 
and collagen type IV, and to a lesser extent fibronectin.  MSC-spheres also contain 
these ECM proteins within the sphere as well as neurocan and vimentin, and express 
several cell adhesion receptors.  Interestingly, MSC-spheres also downregulate β-actin 
and nanog expression compared to the pre-sphere MSCs.  The addition of 
neurotrophins during the sphere induction also increases nestin expression.  Once 
characterized, these MSC-spheres may be a useful donor cell source for future 
neurotransplantation studies. 
 
To produce donor cells for transplantation into the brain, we identified several desirable 
criteria, including a less heterogeneous population of cells and a reproducible method by 
which to culture donor cells in large numbers.  The donor cells should also be able to be 
delivered through a syringe in a densely packed manner so that the transplantation does 
not induce further damage to the brain by its volume.  It may also be beneficial to begin 
with a population of cells which are migratory and possess some of the characteristics of 
neuroprogenitor cells.  Together these criteria may improve donor cell survival and 
influence regeneration in the injured brain.  
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Using the low density method, we were able to isolate a reproducible population of cells 
which were then induced to form multicellular MSC-spheres.  MSC-PA that were isolated 
by the plastic adherence method did not form spheres by this method.  There may be 
several explanations for this observation, including that the MSC-PA may have had more 
residual hematopoetic cells which do not usually from large multicellular aggregates.  
Alternately, by the low density method, we may have selected for a cell type which forms 
spheres more readily. 
 
The use of the rotary shaker in the MSC-sphere induction adds an interesting dynamic to 
the culture technique.  While we characterized more extensively the effect of varying the 
rotary speed and density of plating, there are several other parameters which also 
influenced the cells in this environment.  The forces exerted on the spheres by the rotary 
motion are quite complex but are influenced by several factors including, but not limited 
to, the size of the dish, the amount of media in the dish, the distance the sphere is 
located from the center of the dish, the viscosity of the liquid, and whether the dish is 
kept at a constant velocity.  While the mechanics involved are beyond the scope of this 
manuscript, it is important to acknowledge that there are many other potential 
mechanisms by which to control the sphere formation. 
 
Other methods of sphere formation exist including the hanging drop method; however, 
the rotary shaker produces many more spheres and is less labor intensive to produce 
enough spheres for transplantation.  One variation on the rotary method which may be 
worth exploring would be the use of an orbital shaker rather than the planar rotary 
shaker.  Other future directions include the use of larger culture volumes.   
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The definition of a neurosphere is somewhat vague in that it is usually defined as a 
nestin-positive cell aggregation that can give rise to the three types of neural cells: 
neurons, astrocytes, and oligodendrocytes.  There are different stages of neural 
progenitor development and several different cell populations have been isolated at 
different ages from the brain with FGF-responsive cells being found earlier than EGF-
responsive cells (Ciccolini and Svendsen 1998; Ciccolini 2001).  While the addition of 
EGF to the MSC-sphere cultures enhances their growth and viability, EGF is not 
sufficient or necessary to form MSC-spheres.  On the other hand, FGF is both necessary 
and sufficient to produce MSC-spheres. 
 
The downregulation of β-actin expression in the MSC-sphere is interesting, and may 
have multiple possible interpretations.  One potential explanation is simply the shape of 
the cells within the sphere does not require as much β-actin in their cytoskeleton.  
Therefore, the cells may not make as much β-actin in this configuration.  It is also 
possible that the MSCs are expressing another type of actin or other cytoskeletal protein 
(such as vimentin which is a major intermediate filament in mesenchymal cells) instead 
when they are in the MSC-sphere conformation.  Alternately, it is possible that there is 
simply less cytoplasm and therefore less cytoskeleton in general in the MSC-spheres 
since they appear smaller in size in the MSC-spheres than in adherent culture.  While 
the cause is interesting, one practical implication of the downregulation of β-actin is that 
another method of tracking the MSCs will be required in order to visualize the cells 
following transplantation. 
 
The downregulation of nanog expression and upregulation of nestin expression may 
suggest that the cells are differentiating to some extent in the spheres.  Nanog is 
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expressed in embryonic stem cells and thought to be a key factor in maintaining 
pluripotency.  The decrease in nanog expression when the MSCs are cultured as 
spheres may suggest that the sphere configuration is contributing to their differentiation.  
However it is important to note that while the MSCs have a greater expression of nanog 
than the NSCs, both cell types have low levels of expression in comparison to level 
normally seen in embryonic stem cells.  Likewise, the increased expression of nestin in 
the MSC-spheres which are cultured in the presence of neurotrophins may also suggest 
that MSC-spheres are becoming more neuroprogenitor-like.  However, the MSCs are 
still expressing less nestin than NSCs grown in neurospheres.  Regardless, together this 
may be a viable avenue of investigation on inducing the MSCs to a more 
neuroprogenitor-like fate. 
 
Here we have described a novel method by which to induce MSCs to form MSC-spheres 
with the use of induction media and a rotary shaker.  These MSC-spheres are 
reproducible and share some characteristics of neural progenitor cells, and may 
therefore, represent an alternate donor cell source for transplantation.  However, before 
they can be used for this purpose, it will be useful to determine how other parameters 
influence sphere size and MSC differentiation and assessing the efficacy of the MSC-
spheres to rescue neural tissue. 
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CHAPTER 4 
BONE MARROW-DERIVED MESENCHYMAL STEM CELL 
SPHERES DECREASE APOPTOSIS IN  
INJURED 3-D CO-CULTURE TESTBEDS 
 
4.1 Introduction 
We utilized an in vitro injury testbed, consisting of primary neurons and astrocytes in a 3-
D construct, to evaluate the effect of MSC-spheres on degenerating neurons.  These 
constructs were developed in our lab and have been characterized previously with 
neural stem cells (Cullen (in press)-b).  Here, we first tested the electrophysiological 
properties of the cells within the constructs which adds to the strength of the testbed as 
a model which supports healthy, functional neurons.  Then, we use the testbed to inject 
bone-marrow derived mesenchymal stem cells (MSCs) which have been primed in vitro 
to form MSC-spheres into an injured environment.  By using the testbed, we are able to 
test cells and delivery vehicles in a controlled manner prior to transplantation in an 
animal, thereby optimizing some aspects of the transplant in vitro and decreasing the 
number of animal subjects required. 
 
3-D Co-culture Testbeds 
Cells are influenced by complex environmental stimuli, central to which is the local 
microenvironment, as extracellular context profoundly affects cell behavior.  For 
example, the matrix surrounding cells has been shown to have widespread effects on 
cellular behavior for a variety of cell types (Cukierman et al. 2001; Yamada et al. 2003; 
Schindler et al. 2006) including neural cells (Venstrom and Reichardt 1993; Kiryushko et 
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al. 2004; Loers and Schachner 2007).  Cell-cell and cell-matrix interactions are 
inherently different in the intact organism than in monolayer cell culture (Cukierman et al. 
2001; Yamada et al. 2003), therefore the projection of cell culture-based results to in 
vivo systems is not without numerous caveats.  Cells cultured in a 3-D environment have 
been shown to better represent in vivo cellular behavior than cells cultured in a 
monolayer in several cell types (Schindler et al. 2006; Smalley et al. 2006).  For 
example, planar culture of chondrocytes results in de-differentiation, whereas 3-D 
chondrocyte cultures maintain the expression of chondrogenic markers aggrecan and 
collagen type II (Benya and Shaffer 1982; Kimura et al. 1984; Buschmann et al. 1992).  
Similarly, cardiomyocytes in 3-D culture maintain more in vivo-like molecular and 
electrophysiological characteristics than those cultured in monolayers (Bursac et al. 
2003).  A growing body of evidence suggests that cells grown in planar cultures do not 
have the same morphology (Friedl et al. 1998; Cukierman et al. 2001), proliferation rates 
(Hindie et al. 2006; Willerth et al. 2006), migration (Friedl et al. 1998), gene expression 
(Birgersdotter et al. 2005; Liu et al. 2006b; Yefang et al. 2007), differentiation (Chun et 
al. 2006; Willerth et al. 2006; Yefang et al. 2007), cellular signaling (Pedersen and 
Swartz 2005), or pathological susceptibility (Behravesh et al. 2005; Hindie et al. 2006; 
Smalley et al. 2006) as in 3-D culture or in vivo.  These findings raise questions about 
the appropriateness of employing monolayer culture models to study whole organism 
phenomena. 
 
In the context of recording cellular electrical activity, alterations in ion channel 
expression, membrane permeability, and the cellular microenvironment (including ion 
concentrations and pH) can affect the static and dynamic electrophysiological properties 
of cells.  For example, in 3-D culture, Na+/H+ exchangers have been shown to have 
polarized expression to the apical membrane, which is difficult to maintain in monolayer 
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cultures (Castillon et al. 2002).  In addition, neurons in 2-D have been reported to have 
exaggerated Ca2+ dynamics in comparison to 3-D (Mao and Kisaalita 2004; Desai et al. 
2006; Xu et al. 2006).  Therefore, the establishment of a 3-D culture system for the study 
of electrophysiological properties may provide insight into cellular behaviors that more 
closely mimic those seen in the intact CNS. 
 
Here we describe a novel 3-D construct of neurons and astrocytes within a bioactive 
scaffold consisting of extracellular matrix-derived proteins and proteoglycans.  These 
culture conditions support considerable process outgrowth, complex 3-D morphologies, 
and neurons remain viable over several weeks in culture.  Neurons within these cultures 
demonstrate spontaneously electrical activity and exhibit signs of functional synapse 
formation and network properties.  We propose that these constructs may be better 
platform for a variety of neural research avenues than the current 2-D monolayer culture, 
as they more closely mimic in vivo cytoarchitecture and function. 
 
3-D Co-cultures as a Testbed for Apoptosis in the Injured Environment 
A traumatic insult to the brain results in immediate death and dysfunction of neural cells 
and also triggers a secondary cascade which results in sustained complications 
including inflammation, excitotoxicity, and breakdown of the blood-brain barrier which 
may result in cell death for months after the initial traumatic event (Conti et al. 1998; 
Bramlett and Dietrich 2002).  While much cell death that occurs immediately following 
the primary injury is necrotic, the post-injury environment also activates apoptotic 
pathways (Wong et al. 2005; Zhang et al. 2005; Byrnes and Faden 2007). 
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Since the effects of the injury are sustained and multifactorial, it may be beneficial to 
provide a treatment approach which can act over a prolonged period of time.  Stem cell 
transplantation may facilitate recovery by playing a role in counteracting secondary 
damage, reconstructing damaged tissue, providing continuous trophic support, 
mediating cell-cell repair, and/or replacing neural cells (for review see (Longhi et al. 
2005).  Bone marrow-derived mesenchymal stem cells (MSCs) have been reported to 
decrease apoptosis in injured neurons most likely through secreted factors (Chen et al. 
2002; Crigler et al. 2006).  MSC-spheres which have been induced to form cell 
aggregates may also decrease apoptosis of host cells. 
 
Optimization of donor cells, delivery vehicles, and concentrations will likely require an 
iterative approach and therefore, the utilization of an in vitro testbed could speed this 
process and reduce the number of animal subjects required.  Therefore, we have used 
this testbed model to assess the effect of MSC-sphere injection has on apoptosis in 
injured neural cells. 
 81 
4.2 Methods 
3-D Neuronal-Astrocytic Co-culture Constructs 
Neurons were isolated from embryonic day 17 - 18 Sasco Sprague-Dawley rats (Charles 
River Labs) or GFP+ transgenic C57BL/6-Tg(cAG-EGFP)C14-701-FM1310sb mice 
(C57BL6 background) mice bred in house.  Cerebral cortices were isolated and digested 
in Hank’s buffered salt solution (HBSS) with trypsin (0.25% + 1mM EDTA) at 37ºC for 10 
minutes, followed by mechanical trituration with DNase I (0.15mg/mL).  The cells were 
centrifuged at 1000 rpm for 3 minutes and resuspended in co-culture medium 
(Neurobasal + 2% B-27 + 1% G-5 + 500µM L-glutamine).  Astrocytes were separately 
harvested separately from postnatal day 1 Sprague-Dawley pups.  Isolated cortices were 
minced, digested in trypsin (0.25% + 1mM EDTA) for 3-5 minutes at 37°C, followed by 
DNase I (0.15 mg/ml) treatment and gentle mechanical trituration.  Cells were plated in 
DMEM/F12 with 10% fetal bovine serum.  Mechanically agitation was used to detach 
less adherent cell types at 24 and 72 hours and the primary astrocyte culture (>95% 
type I astrocytes) was passaged upon reaching ~90% confluency for four weeks.  
Astrocytes were used between passages 4-12 for plating in 3-D culture.  
 
Cultures were plated in custom-made cell culture chambers consisting of a glass 
coverslip below a silicone-based elastomer mold (Sylgard 184 and 186, Dow Corning; 
Midland, MI; cross-sectional area = 2 cm2).  Prior to plating, the chambers were pre-
treated with 0.05 mg/mL poly-L-lysine (PLL, Sigma) followed by Matrigel™ (0.5 mL/well 
at 0.5 mg/mL, Becton Dickinson Biosciences; Bedford, MA) in Neurobasal™ medium 
(each treatment was >4 hours).  3-D neuronal-astrocytic co-cultures were plated at a 1:1 
initial neuron:astrocyte ratio at a density of 2500 cells/mm3 in Matrigel™ matrix (500-750 
µm thick; final concentration 7.5mg/mL).  Following Matrigel™ gelation, co-culture 
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medium was added.  Co-cultures were maintained at 37°C and 5% CO2-95% humidified 
air and medium was replaced at 24 hours and every 2 days thereafter.  Experiments 
were initiated at 21 days in vitro (DIV).  All procedures involving animals were approved 
by the Institutional Animal Care and Use Committee (IACUC) of the Georgia Institute of 
Technology.  All cell reagents were obtained from Invitrogen (Carlsbad, CA) or Sigma 
(St. Louis, MO) unless otherwise noted. 
 
Cell Viability 
Cell cultures were incubated with 4 µM ethidium homodimer-1 (EthD-1) and 2 µM 
calcein AM (both from Molecular Probes, Eugene, OR) at 37° C for 30 minutes and then 
rinsed with 0.1M Dulbecco’s phosphate-buffered saline (Invitrogen).  The percentage of 
viable cells was calculated by counting the number of live cells (fluorescing green by 
AM-cleavage) and the number of cells with compromised membranes (nuclei fluorescing 
red by EthD-1).  At 21 DIV, co-culture viability was assessed (n = 18).   
 
Immunocytochemistry 
Cultures were fixed in 3.7% formaldehyde (Fisher, Fairlawn, NJ) for 30 min, rinsed in 
PBS and permeabilized using 0.3% TritonX100 (Kodak, Rochester, NY) + 4% goat 
serum (Invitrogen) for 20 minutes.  Primary antibodies were added (in PBS + 4% serum) 
at 18-24°C for 4 hours.  Secondary fluorophore-conjugated antibodies (FITC or TRITC-
conjugated IgG (Jackson Immuno Research, West Grove, PA) or Alexa 488 or 546-
conjugated IgG (Molecular Probes) were added (in PBS + 4% serum) at 18-24°C for 2 
hours.  Co-cultures were immunostained using primary antibodies recognizing a 
combination of the following intracellular proteins: 1) tau-5 (MS247P, 1:200, 
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NeoMarkers, Fremont, CA), a microtubule-associated protein expressed predominantly 
in neurons, and 2) MAP-2 (rabbit polyclonal antibody; AB5622; 1:200; Chemicon) 3) 
synapsin I (A6442, 1:200, Molecular Probes), a synaptic vesicle protein localized in 
presynaptic specializations (Fletcher et al. 1991).  Counterstaining was performed using 
Hoechst 33258 (1:1000, Molecular Probes).   
 
Fluorescence Microscopy 
Cells were viewed using confocal laser-scanning microscopy (LSM 510, Zeiss, 
Oberkochen, Germany) or epifluorescence microscopy (Nikon TE-300, Melville, NY). 
Images were analyzed using LSM Image Browser (Zeiss) or Image-Pro Plus (Media 
Cybernetics, Silver Spring, MD). 
 
Image Processing 
All processing was performed in ImageJ (U. S. National Institutes of Health, Bethesda, 
Maryland) with built-in with custom libraries and with the VolumeJ plugin (Abramoff and 
Viergever 2002).  Briefly, z-stacks (512X512X18; optical slice thickness of 4.3 mm) were 
converted from RGB to 8-bit grayscale.  Stacks were thresholded in intensity (to 
accentuate thin dendrites) using the middle-z-axis plane as a reference point.  
Histograms were summed along the z-axis and normalized (full-range grayscale). Stacks 
were linearly interpolated in the z-direction. Image was volume rendered with ray-casting 
algorithm using a Levoy depth-cueing classifier (makes voxels more opaque the closer 
their intensity is to a user-defined threshold and the higher their surface gradient with 
voxel brightness decreasing with distance).  Color mapping was determined from a 
grayscale intensity-ramped index volume created with the same interpolation parameters 
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used on the stacks.  Volume-rendered images were despeckled using a median filter 
with 2-pixel radius.  Histograms for volume-rendered images were then normalized. 
 
Scanning Electron Micrograph 
Cell morphology and the spatial distribution of cell-cell and cell-matrix interactions were 
qualitatively assessed through low voltage, high resolution scanning electron microscopy 
(LVHR-SEM).  Co-cultures were fixed using 2.5% EM-grade glutaraldehyde in 0.1M 
cacodylate buffer (pH 7.4) at 4°C for 24 hours, washed in di-H2O, and then post-fixed 
with 1% OsO4 in 0.1M cacodylate buffer (pH 7.4) for 1 hour followed by several rinses.  
Co-cultures were dehydrated using ethanol (30, 50, 70, 3 x 100%, 15 min each), 
wrapped in parafilm, and loaded into a Polaron E-3000 critical point dryer (CPD) and 
exchange with CO2 was made while monitoring the exhaust gas rate.  The CPD was 
thermally regulated to the critical temperature and pressure and, following phase 
transition, the CO2 gas was released at a constant flow rate.  Prior to LVHR-SEM, all 
specimens were sputter coated with 3 nm of chromium.  
 
Whole-cell Patch Clamp 
For all patch clamp recordings, borosilicate glass electrodes with filaments (external 
diameter 1.5 mm; inner diameter 0.75 mm; Sutter Instruments, Novato, CA) were pulled 
on a laser puller (P-2000; Sutter Instruments) with a 7-10 MΩ resistance.  Electrodes 
were back-filled with internal solution (140mM K-gluconate, 10mM HEPES, 5mM Kcl, 
0.1mM K-EGTA, 3mM Na-ATP, 0.3mM GTP; pH 7.3; 315-325 mOsm).  The external 
solution used was artificial cerebral spinal fluid (aCSF) containing 119mM NaCl, 2.5mM 
KCl, 1.3mM MgCl2, 2.5mM CaCl2, 1mM NaH2PO4, 26.2 NaHCO3, 11mM glucose (pH 7.4 
by bubbling with CO2/O2 (95/5) mixture; 320 mOsm) made daily and gravity perfused.  A 
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separate perfusion tube was used to add the high K+ solution (20nM in external solution) 
which flowed into the bath solution at 1-2 mL/min.  The normal perfusion system 
continued to flow during high K+ influx and efflux experiments.  An AxoPatch 1D (Axon 
Instruments) patch-clamp amplifier coupled with a Digidata acquisition PCI card, and 
WinWCP software (University of Strathclyde, Glasgow, U.K.; http://www.bio-
logic.info/electrophysiology/winwcpandwinedr.html) was used for data acquisition, 
recording and stimulating. Recordings were displayed on Tektronix Oscilloscopes (TDS 
3014B and 7603) and analyzed offline in WinWCP and Igor Pro (WaveMetrics). 
 
Mesenchymal Stem Cell Culture 
Harvest and Isolation of MSCs 
MSCs were isolated and harvested as described before (Peister et al. 2004) with slight 
modifications.  Whole bone marrow was isolated from the femurs and tibias of 8-10 week 
old male GFP+ transgenic C57BL/6-Tg(cAG-EGFP)C14-701-FM1310sb mice (C57BL6 
background) mice bred in house.  Mice were sacrificed, and bones were dissected out 
and cleaned of muscle and connective tissue.  One end of the bone was clipped and the 
bone marrow extracted by centifugation in modified microcentrifuge tubes.  The pellet 
from each bone was resuspended in Cell Isolation Media (CIM; RPMI-1640, 10% FBS, 
and 10% Horse Serum), mechanically-dissociated by a 22-gauge needle, filtered 
through a 70 µm filter, and plated in a T175 flask.  At 24 hours, non-adherent cells were 
removed, cells were rinsed with DPBS, and fresh CIM was added.  Flasks were fed 
every 3-4 days. After 4 weeks, cells were trypsinized for 2 minutes and re-plated in CIM 
in a T175 flask. Cells that did not detach in 2 minutes were discarded.  After 2 weeks, 
cells were trypsinized for 2 minutes and re-plated in 100 mm tissue culture dishes at a 
density of 50-500 cells/cm2 in Cell Expansion Media (CEM; IMDM, 10% FBS, and 10% 
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Horse Serum).  Once Passage 3 cells were confluent, they were either expanded further 
in 100 mm dishes or frozen (FBS + 10%DMSO).  Cells were used at passages 4-10. 
 
MSC-sphere Induction 
MSCs were expanded to 80-90% confluency in 100 mm tissue culture dishes.  Cells 
were trypsinized, and plated in NeuroBasal A (Invitrogen, Carlsbad, CA) supplemented 
with serum substitute B27 (Invitrogen), insulin (25 µg/mL), transferrin (100 µg/mL), 
putrescine (60 µM), sodium selenite (30 nM), progesterone (20 nM), and L-glutamine in 
100 mm Petri dishes or tissue culture dishes. Cell seeding density was 500,000-750,000 
cells/dish unless stated.  Cells were incubated on a rotary shaker.  Human recombinant 
basic growth factor (bFGF; 10 ng/mL; PreproTech) was added to the media every 2-3 
days. 
 
Injury of 3-D Co-culture Constructs 
3-D co-culture constructs were injured at 21 days in vitro in a cell shearing device 
described previously (LaPlaca et al. 2005; Cullen and LaPlaca 2006; Cullen et al. 2007a; 
Cullen et al. 2007b) at 0.50 E and 30 s-1.  Media was collected before injury and new 
media was replaced following the injury.  Control non-injured cultures were removed 
from the incubator for the same length of time and received a media change.  All 
cultures were returned to the incubator for 48 hours. 
 
Injection of MSC-spheres into the Co-culture Testbed 
At 48 hours post-injury, MSC-spheres were injected though a Hamilton syringe into the 
center of the 3-D injury testbed.  Cells were injected in 2.5 µL of HBSS at a 
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concentration of 6.0 x 103 cells/µL (1.5 x 104 cell total per culture)(n=3-4 per condition).  
Cultures were returned to the incubator for 72 hours following injection. 
 
Apoptosis Assay 
Caspase levels were quantified at 3 days post-injection by the Caspatag 3,7 Assay 
(Chemicon APT523).  Briefly, the reagent was reconstituted according to the instructions 
(dissolved lyophilized reagent with 50µL DMSO; 1:150 stock; then diluted with media) 
and 250 µL was added to each culture for 1 hour @ 37°C.  Caspatag reagent was 
removed and cultures were counterstained with Hoechst.  Cultures were imaged on a 




For viability and immunocytochemical assays, three to five randomly selected regions 
per culture were counted and averaged.  Standard deviations were calculated when 
appropriate.  Statistical values were calculated by paired, 2-tailed t-tests with p-value < 
0.05 considered significant.  For the caspae assay, a two-way ANOVA was performed 




3-D Co-culture Constructs are Electrophysiologically Active 
We have developed a novel neural 3-D co-culture construct to be used as an in vitro 
model of neural tissue.  These constructs consist of cerebral cortical neurons and 
astrocytes within a Matrigel™ matrix, which is biologically active for neural cells through 
the matrix components (e.g., laminin, collagen IV, entactin, heparan sulfate 
proteoglycan) (Kleinman et al. 1986) and cytokine-related interactions (Vukicevic et al. 
1992).  Constructs were maintained using a defined, serum-free, Neurobasal™ medium 
for up to 60 days.  The 3-D neural constructs contract and rise from the culture surface 
during the first week in vitro, likely due reactive forces on matrix fibrils resisting tension 
associated with process outgrowth, a phenomenon observed in similar 3-D collagen 
(e.g., fibroblasts(Grinnell et al. 2006)) and collagen-glycosaminoglycan matrices (e.g., 
peripheral nerve explants(Spilker et al. 2001)).  This contraction results in a ~50% 
reduction in culture diameter (to 7-9 mm), a ~25% reduction in thickness (to 500-600 
µm), with a concomitant 3.5-fold increase in 3-D cell density (to ~9000 cells/mm3).  
Following this contraction, the constructs are similar in size and opacity to acute cortical 
slices of rodent brains (Figure 4.1A) and cells can be visualized to a depth of 
approximately 100 µm with differential interference contrast (DIC) and near-infrared 
optics.   
 
The cultures can be plated in a variety of neuron-to-astrocyte ratios (1:1 in the present 
study) that have >95% viability at 21 days (Cullen (in press)-a).  We have maintained 
viable 3-D neural constructs for over 60 days in vitro using this method.  This method 
utilizes separate neuronal and astrocytic harvests, such that neurons isolated from 
GFP+ transgenic mice, mixed with wild-type astrocytes, greatly enhance the ability to 
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distinguish neurons for electrophysiological assessment.  Immunocytochemistry reveals 
that neurons within the constructs express the neuronal-specific proteins MAP-2 and 
tau-5 (Figure 4.1B).  The initial neuron-to-astrocyte ratio, coupled with modest levels of 
astrocyte proliferation influence the relative neuronal presence in mature cultures.  For 
instance, an initial 1:1 neuron-to-astrocyte ratio yields cultures that are ~10% neuronal 
by 21 days in vitro (data not shown).  Extensive processes extending from cells are 
visible under bright field microscopy by 7 days and become more pronounced as the 
culture matures.  Morphologically, neurons within the constructs exhibit spherical somata 
with processes extending throughout 3-D space.  Processes within 2-D cultures are 
constrained to an approximately planar region, while those in 3-D constructs traverse 








Figure 4.1: Gross and micro-morphology of 3-D 
constructs. A) Within a few days of plating, 3-D constructs 
contract and lift off the culture surface taking on a shape 
similar to an acute slice.  B) Morphology of a fluorescently-
labeled neuron in a 3-D culture extending processes in all 
directions. Neurons within the constructs express the 
neuronal-specific proteins MAP-2 and tau-5. (Submitted Irons, 
et al. 2007) 
A) B) 
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The 3-D constructs are similar in size and shape to acute brain slices, which allowed the 
use of a modified acute slice patch clamp rig and perfusion system for 
electrophysiological recording.  We found unique challenges to recording from cells 
within 3-D cultures including an increased susceptibility to mechanical vibrations than 
acute slices, which required additional anchoring.  In addition, the construct was more 
adhesive and denser than acute slices from young rodent brains.  Consequently, it was 
more difficult to penetrate the extracellular matrix with an electrode; however, by 
maintaining strong positive pressure on the electrode and a diagonal approach angle, 
successful recordings were achieved.  While there was some difficulty establishing 
intracellular access for sub-surface cells, this challenge was not unique to our constructs 
and was overcome with a modified approach.  Similar challenges have been reported 
with 3-D collagen I cultures (O'Shaughnessy et al. 2003); however, in those cultures, the 
cells were seeded on top of partially formed gels and hence the cells recorded from were 
at or near the surface of the gel.  In contrast, we were able to access cells substantially 
below the surface.  The ability to access cells at increasing depths may be improved by 
altering the concentration or constituents of the matrix; however, decreasing the Matrigel 
concentration below 5.0 mg/mL resulted in more fragile cultures and increased their 




Figure 4.2:  Comparison of 2-D (left) and 3-D (right) cultures.  Volume-rendered z-
stacks are color-coded for depth from the objective lens.  While most of the 2-D culture 
neurites are restricted to a planar region, in the 3-D cultures they traverse much larger z-
distances (see arrows). (Submitted Irons, et al. 2007) 
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Using techniques modified from traditional acute slice whole-cell patch clamp recordings, 
we successfully recorded from cells within the 3-D co-culture constructs (Figure 4.3A).  
Neurons within the 3-D constructs exhibited excitable membrane properties including 
spontaneous and evoked action potentials.  Cells within the 3-D constructs were 
observed to have typical resting membrane potentials (–56.2 ± 11.5 mV; n=28) which 
were not statistically different from neurons in similar 2-D cultures (–52.8 ± 6.1 mV; 
n=12; t-test p=0.35).  In addition, action potentials of neurons within the 3-D constructs 
had large action potential amplitudes (70.3 ± 9.9 mV) similar to mature neurons.  
Neurons within the 3-D cultures exhibited depolarization and repetitive spiking with an 
increased discharge frequency in response to an increase in extracellular K+ 
concentration (Figure 4.3B).  Membrane potential and firing rate returned to original 
levels within 3 minutes after K+ washout (data not shown).  Together, these data 
suggest the neurons within the 3-D constructs express functional voltage-gated ion 
channels and exhibited action potentials similar to those observed in acute slices, with 







Figure 4.3:  Whole-cell patch clamp 
recording in 3-D constructs. A:  Patch 
clamp electrode in GFP+ neuron within 
a 3-D construct. Using modified 
techniques normally used with acute 
slice whole-cell patch clamp recording, 
we were able to record from cells within 
the 3-D co-cultures. Neurons isolated 
from a GFP+ transgenic mouse were 
cultured with wildtype astrocytes to 
facilitate identification of neurons within 
the culture. (inset) Spontaneous action 
potentials from a neuron within a 3-D 
co-culture. B: Active response of a 
neuron to a 20 pA/s current ramp (100 
pA maximum; top) and to high, 
extracellular K+.  Extracellular K+ 
perfusion (20mM) evoked an increase in 
spiking and an elevated resting 
membrane potential. (Submitted Irons, 
et al. 2007) 
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We also observed evidence of functional synapses and network activity within the 3-D 
co-culture constructs.  Fluorescent immunocytochemistry of representative cultures at 21 
days in vitro revealed abundant synapsin I expression (Figure 4.4A; green puncta) 
along with the neuronal marker tau-5 (red).  Electrophysiologically, spontaneous 
synaptic activity was evident (Figure 4.4B; black circles), as was network-driven burst 
activity.  Additionally, through scanning electron microscopy, we observed processes 
with the characteristic appearance of neurites extending across somata and culminating 
in synaptic terminals (Figure 4.4C).  Together, these observations provide significant 















Figure 4.4. Evidence of functional synapses and network activity in 3-D 
constructs. A: Immunofluorescent photomicrographs of representative cultures at 21 
days in vitro. Triple-labeled for neuronal marker tau (red), synaptic marker synapsin 
(green puncta), and nuclear marker Hoechst 33258 (blue). B: Spontaneous synaptic 
activity was evident above the baseline noise (black circles) as was network-driven burst 
activity. C: Scanning electron microscope image of a synapse (arrow) within a 3-D 




MSC-spheres injected into injured 3-D testbed decrease apoptosis 
MSC-spheres were injected into 3-D co-culture construct testbeds 48 hours after in vitro 
cell shearing injury.  At 3 days post-injection, caspase levels were quantified in the 
culture.  We observed a significant increase in caspase-positive injured construct cells 
verses non-injured controls (n=3-4; p-value <0.05 by two-way ANOVA).  The injection of 
MSC-spheres into the injured constructs decreased the host caspase level by a 
statistically significant amount (Figure 4.5)(n=3-4 per condition; p-value <0.05 by two-







Figure 4.5: MSC-spheres decreased host caspase levels at 5 days post-injury in a 
3-D co-culture testbed when MSC-spheres were injected 48 hours following an in vitro 




3-D Co-culture Constructs are Electrophysiologically Active 
We have engineered 3-D co-culture constructs as a model of neural tissue composed of 
neurons and astrocytes within a bioactive matrix.  Cells within these cultures exhibit in 
vivo-like somatic morphologies with extensive process outgrowth, high viability, 
spontaneous excitable properties, and evidence of functional network connections.  
These 3-D constructs are similar in size and opacity to acute slices and also have the 
distinct advantage of being able to be reliably reproduced with a variety of initial cell 
types and ratios, thus presenting a novel model for neural tissue studies that benefit 
from reliable electrophysiological measurements as outcome metrics. 
 
Cells in vivo are intimately connected to each other and the surrounding extracellular 
matrix forming a complex microenvironment that is not reproduced in traditional culture 
systems.  Suitable 3-D microenvironments must support neural cell attachment while 
allowing sufficient diffusion of nutrients to keep the culture viable for long-term studies.  
In addition, the microenvironment should sufficiently support neurite outgrowth and the 
formation of functional synapses.  Of previously existing 3-D primary neural cell cultures, 
many incorporate scaffolds of collagen (Coates et al. 1992; O'Connor et al. 2000a), 
agarose (Yu et al. 1999; Luo and Shoichet 2004) or fibrin (Willerth et al. 2006) with 
varying viability.  Survival of primary neurons in agarose is poor beyond ten days 
(O'Connor et al. 2001), however neurite outgrowth can be improved by the addition of 
collagen type IV (Cullen et al. 2007a) or laminin (Yu et al. 1999).  Collagen I matrices, 
either alone or mixed with agarose, have also shown some improvement for the growth 
of neurons, astrocytes, and neural progenitor cells (O'Connor et al. 2000a), however the 
addition of bioactive ECM constituents more representative of those found in the 
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developing or mature brain (e.g. laminin, hyaluronan, or proteoglycans) may further 
increase the survival, function, and relevance of cultured neural cells.   
 
Hydrogels such as Matrigel have several advantages as scaffolds for 3-D cultures.  
Several groups have reported the use of hydrogel-based 3-D neural cultures of either 
agarose or collagen type I; however, although commonly used as a scaffold for many 
other cell types, collagen I may not be the most appropriate scaffold for neural cells.  We 
utilized Matrigel matrix, a reconstituted basement membrane derived from the 
Engelbreth-Holm-Swarm mouse sarcoma, which is biologically active for neural cells 
through matrix (e.g., laminin, collagen IV, entactin, heparan sulfate 
proteoglycan)(Kleinman et al. 1986) and cytokine-related interactions (Vukicevic et al. 
1992).  Despite the clear benefits for Matrigel in a 3-D culture system, alternative 
biomimetic scaffolds, such as methylcellulose (Stabenfeldt et al. 2006) or agarose 
(Cullen et al. 2007a) may allow more control over the presentation of extracellular matrix 
ligands while continuing to provide the support necessary for neuronal function.   
 
In addition, the presence of astrocytes may also influence electrophysiological 
properties.  Specifically, astrocytes serve as substrates for neurite outgrowth, provide 
trophic factors and metabolic precursors, and regulate neuromodulation, synaptic 
efficacy, and synapse number (Tsacopoulos and Magistretti 1996; Ullian et al. 2001).  
The intimate interaction between neurons and astrocytes across three-dimensions is 
essential to recapitulate phenomena observed in vivo.  Since transformed cell lines have 
been shown the have incomplete synapse formation (Pancrazio et al. 1999), altered ion-
channel expression (Pancrazio et al. 1999) or abnormal resting membrane potentials (< -
40 mV)(Desai et al. 2006; Wu et al. 2006), primary cell cultures incorporating both 
neurons and astrocytes may be more requisite for electrophysiological studies.  An 
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additional advantage of building 3-D co-culture constructs from dissociated cells is that 
neurons and glial cells from different transgenic sources can be incorporated.  In this 
work, we have used neurons isolated from GFP+ or YFP+ transgenic mice mixed with 
wild-type astrocytes, which allows easier identification of neurons.  This flexibility opens 
the door to a wide range of applications with different transgenic sources to address 
specific mechanistic questions. 
 
Although morphology and neuronal marker expression are valid indicators of phenotypic 
maturity, the ultimate attribute of healthy neurons is the ability to generate action 
potentials and form synapses.  Neurons within the 3-D cultures exhibited spontaneous 
excitable properties along with evidence of synaptic currents and network activity.  
These traits allow the cultures to be used in studies of intercellular properties given the 
ability to interface with multiple electrodes within a culture. 
 
In summary, the differences between 3-D, ECM-based cultures and monolayer cultures 
cannot be ignored and may impact cellular responses significantly.  Physiologically 
relevant models of neural tissue require prioritization among complexity, control, and 
reproducibility.  Although typical in vitro cell preparations (e.g., planar cultures) have 
yielded important neurophysiological information, the conditions used in these studies 
vary significantly from those found in the highly complex system of the whole organism 
and therefore may influence individual cellular functions.  3-D culture models consisting 
of multiple neural cell types are capable of maintaining many positive aspects of in vitro 
modeling while approximating the cytoarchitecture of the brain to a greater extent than 
traditional planar cultures (Bass et al. 1971; Williams and Herrup 1988).  The 3-D neural 
co-cultures presented here represent an important step towards more physiologically-
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conformant neural tissue models having many distinct advantages for 
electrophysiological applications. 
 
MSC-spheres reduce host caspase levels in injured testbeds 
The injection of MSC-spheres into injured 3-D co-culture testbeds significantly reduced 
the host apoptosis following in vitro injury.  The effect seen in the MSC-sphere injected 
groups may be due to a variety of factors.  MSCs have been reported to decrease cell 
death through secreted factors including neurotrophins, for example brain-derived 
neruotrophic factor (BDNF) and nerve growth factor (NGF) (Chen et al. 2002; Gao et al. 
2005; Crigler et al. 2006).  BDNF and NGF have many survival regulatory roles in the 
brain both in development and in the adult brain (for review see (Hempstead 2006)). 
 
Therefore, it will be interesting to assess whether MSC-spheres are secreting 
neurotrophins while in culture.  Preliminary experiments indicate that they are producing 
some amount of BDNF during induction.  If this is the case, it may be possible to prime 
the MSC-spheres to produce more BDNF prior to transplantation through incubation with 
NGF or neurotrophin-3 which have been shown to influence each other’s secretion in 
cortical neurons in a complex pathway (Patz and Wahle 2004).  Experiments to 
determine the expression of neurotrophins by MSCs are ongoing in our laboratory and 
may provide insight into one area that MSCs may be influencing the host response. 
 
Other explanations are also possible for the observed decrease in apoptosis.  Since 
macrophages and microglia are potential components and/or differentiation products of 
MSC-spheres, it is possible that the addition of MSCs is decreasing the host caspase 
level by the destruction of dying cells rather than preventing apoptosis.  However, the 
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level of CD11b (marcophage marker) observed in MSCs cultures by our method is low 
as is the total cell number injected, so macrophage activity would be expected to have a 
more modest effect.  Nevertheless, it cannot be ruled out without further 
experimentation. 
 
The observed decrease in apoptosis in the injured testbeds is encouraging for the use of 
MSC-spheres as a donor cell source.  The next step towards this end will be aimed at 
assessing if MSC-spheres have a similar effect once transplanted into the injured brain, 
and by what method they are providing benefit to the host cells. 
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CHAPTER 5 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
The incidence and long-term effects of traumatic brain injury make it a major healthcare 
and socioeconomic concern.  Cell transplantation may be an alternative therapy option 
to target prolonged neurological deficits; however, in order to be used clinically, the 
safety and efficacy must be determined.  Of the currently-used cell types available, bone 
marrow-derived mesenchymal stem cells (MSCs) are an easily accessible and 
expandable cell type which also circumvents the ethical dilemmas surrounding the use 
of fetal tissues.  However, like all other cell types, they must also be proven efficacious.  
A major disappointment of other central nervous system cell therapies in clinical trials 
has been the lack of consistency in functional recovery where some patients receive 
great benefits while other experience little if any effect (Watts and Dunnett 2000; Lindvall 
and Bjorklund 2004).  There are many possible explanations for this variability including 
genetic and environmental factors, surgical techniques, and donor cell phenotype.  Of 
these, one of the most easily addressable is the homogeneity of donor cells. 
 
Here, we present data from an animal study which similar to many clinical trials was 
inconclusive.  A few individual mice that received transplants made impressive 
behavioral recoveries while others did not.  While many groups are exploring other cell 
types to use, few focus to standardize and improve the isolation and pre-transplantation 
culture protocols.  Our goal was to produce a reproducible population of MSCs and to 
induce them in vitro to form cell aggregates which resemble neurospheres.   
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We began by comparing isolation and expansion protocols of MSCs.  Two of the most 
common isolation techniques are the plastic adherence method where cells are cultures 
in medium to high density in 20% serum.  After 1-3 days, the media and all non-adherent 
cells are removed.  At this point, the cells are expanded and used at various passages.  
While this method effectively removes red blood cells and some other cell types, it does 
not select for MSCs as many other cell types in the bone marrow are adherent.  As the 
cells are passaged, they probably become less heterogeneous by simple selection, but 
cells in long-term culture and many passages may have altered gene expression 
patterns.  We compared the plastic adherence method to the low-density method in their 
production of MSCs.  The low density method used a minimal nutrient media with the 
intent to essentially starve off the non-MSC cell types leaving a purer population.  We 
compared the efficiency of these MSC isolation methods in their ability to isolate cells 
which fit two of the criteria normally associated with MSCs: 1) the lack of hematopoietic 
cell surface markers and 2) the ability to differentiate into osteoblasts and adipocytes.   
The MSCs cultured at low density were more homogeneous in morphology, expressed 
lower levels of hematopoetic cell surface markers, and had a greater percentage of cells 
which differentiated into adipocytes and osteoblasts.  Therefore, the low density isolation 
method was used in the rest of the experiments. 
 
By using a combination of media, cell culture constituents, and growth factors normally 
used to culture neural stem cells (NSCs) and primary neurons, we were able to produce 
multicellular aggregates of MSCs (referred to as MSC-spheres).  When grown in 
standard tissue culture plates, the spheres require 7-10 days to form and have a range 
of sizes.  However, by adding dynamic rotary motion MSC-spheres formed more quickly 
and were more consistent in size and shape.  
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The speed and the seeding density are two parameters we identified that influenced the 
size and quantity of the MSC-spheres.  By using this method, MSC-spheres can be 
produced reliably at a consistent range of radii.  This level of control may be 
advantageous in the future if a particular sphere size is desired.  For our purposes, we 
chose 40 rpm because it produced consistent spheres that were able to be transplanted 
through a 10 µL syringe.  Larger spheres were eliminated as they tended to clog the 
syringe.  However, larger cell spheres may be helpful in experiments involving 
differentiation or to compare MSC-spheres to embryoid bodies as the larger size may 
influence differentiation signals.  However, it will be important to assess the diffusion 
limits of nutrients and oxygen into the spheres if larger spheres are used to avoid a 
necrotic core. 
 
We also explored the interaction of MSCs with their extracellular environment.  We found 
that MSCs migrated on extracellular proteins laminin and collagen IV to a greater extent 
than fibronectin.  Interestingly, by immunocytochemistry, the spheres appear to produce 
more fibronectin than collagen type IV.  Another interesting observation is that the MSC-
spheres varied in their migratory distance based on whether they were centrifuged 
before being plated.  Those spheres that were centrifuged migrated farther and faster 
suggesting that the centrifuge may be stimulating migration possibly through a 
mechanotransduction signaling mechanism.  Alternately, it is possible that by allowing 
the spheres to settle we are selecting against a population of slowly migrating cells, 
however this seems less likely as the spheres are relatively the same size and settling is 
a function of size and density. 
 
For reasons that are not clear, the MSCs appear to express low levels of GFP despite 
being isolated from a homozygous transgenic mouse.  The GFP transgene is on an β-
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actin promotor and is normally expressed constitutively.  The lack of GFP in the cells is 
puzzling as they appear to express β-actin in the adherent expansion stage, but 
decrease expression in the MSC-spheres.  However, the MSC-spheres appear dense 
with nuclei and comparatively little cytoplasm, so it is possible that the decreased β-actin 
level is a result of their conformation.  It is also possible they are using a different 
structural protein such as vimentin.  Either way, another cell tracking mechanism will 
need to be used to track the cells following transplantation as GFP expression from the 
β-actin promoter may be unreliable. 
 
The MSC-spheres share some characteristics of neural stem cells (NSCs).  Neural stem 
cells are often cultured in suspension in neurospheres, however the MSC-spheres are 
significantly larger than NSCs (and smaller than embryoid bodies).  MSC-spheres also 
resemble the NSCs by their dependence on bFGF for sphere formation.  NSCs 
harvested at earlier timepoints in development, are also EGF-responsive.  While the 
MSC-spheres are not dependent on EGF for sphere formation, EGF influences both 
viability and early sphere formation.  In addition, MSC-spheres produce nestin, a 
neuroprogenitor marker.  Nestin expression in increased by the induction of MSC-
spheres in the presence of neruotrophins.  Interestingly, the expression of nanog (a 
marker of pluripotency) decreases in MSC-spheres compared to adherent MSCs, 
however, it is only produced at low levels even in the adherent MSCs. 
 
Once the MSC-spheres had been characterized, we injected them into an in vitro injury 
testbed consisting of a 3-D culture of neurons and astrocytes in Matrigel injured in a cell 
shearing device .  After injury in vitro, the testbed reproduces some aspects of the injury 
environment including apoptosis of host cells (Cullen (in press)-b).  When MSC-spheres 
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were injected into the injured environment of the testbed we detected a significant 
decrease in caspase activation of host cells compared to the injured control. 
 
In the end, this work set the groundwork for many questions about stem cells and their 
role in injury.  What adhesion molecules are at work in the MSC-spheres?  What 
different genes are being expressed during sphere formation compared to adherent 
culture?  How do MSC-spheres compare to other cell aggregates such as NSC 
neurospheres and embryoid bodies both in vivo and in vitro?  Can we use this system to 
upregulate trophic factor production to improve the potential beneficial effect on injured 
cells?  If so, what factors should be target?  Can MSC-spheres cultured by this new 
method improve functional recovery to a greater extent than we saw previously?   
 
In conclusion, we determined that MSCs may be an alternative cell donor cell type for 
cell therapy after traumatic brain injury.  We also learned that MSCs have the ability to 
form spheres in culture and that the spheres size can be controlled by the culture 
system.  The MSC-spheres share some characteristics of NSCs and may decrease host 
cell apoptosis in the injury environment.  Although we are far from understanding the 
signals that contribute to stem cell phenotype and function, each piece brings us closer 
to being able to harness the potential they posses for regenerative medicine and bring 
effective cell therapies one step closer to the clinic.  
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APPENDIX A 
UNSUCCESSFUL INDUCTION METHODS 
 
Many induction methods were attempted before a successful method was found to 
induce MSC-sphere formation.  Some less successful methods are listed here. 
 
Media Formulations 
1) Dulbecco’s modified eagle medium: nutrient mixture F-12 (DMEM/F12, 1:1; 
Invitrogen) supplemented with insulin (25 µg/mL), transferrin (100 µg/mL), 
putrescine (60 µM), sodium selenite (30 nM), progesterone (20 nM), and glucose 
(0.3%).  Human recombinant basic fibroblast growth factor (bFGF; 20 ng/mL; 
PreproTech) added to the media every 2-3 days.   
2) DMEM:F12 supplemented with insulin (25 µg/mL), transferrin (100 µg/mL), 
putrescine (60 µM), sodium selenite (30 nM), progesterone (20 nM), glucose 
(0.3%) and L-glutamine. Human recombinant basic fibroblast growth factor 
(bFGF; 20 ng/mL; PreproTech) added to the media every 2-3 days. 
3) Neuralbasal media with insulin (25 µg/mL), transferrin (100 µg/mL), putrescine 
(60 µM), sodium selenite (30 nM), progesterone (20 nM), glucose (0.3%) and L-
glutamine. Human recombinant basic fibroblast growth factor (bFGF; 20 ng/mL; 
PreproTech) added to the media every 2-3 days 
4) Neuralbasal A media with serum substitute B27 (Invitrogen), EGF (20ng/mL), 
NGF (20 ng/mL), and FGF (20 ng/mL). 
5) DMEM media with serum substitute B27 (Invitrogen), EGF (20ng/mL), NGF (20 
ng/mL), FGF (20 ng/mL), and retinoic acid (RA). 
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6) 50:50 mix of DMEM:F12 and Neuralbasal supplemented with insulin (25 µg/mL), 
transferrin (100 µg/mL), putrescine (60 µM), sodium selenite (30 nM), 
progesterone (20 nM), and glucose (0.3%). 
7) 50:50 mix of DMEM:F12 and Neuralbasal A supplemented with insulin (25 
µg/mL), transferrin (100 µg/mL), putrescine (60 µM), sodium selenite (30 nM), 
progesterone (20 nM), and glucose (0.3%). 
 
Culture Dishes 
On the rotary shaker, 6-well plates, 12-well plates, and 35mm, 60mm, and 150mm 
dishes did not work to induce cells.  The cells in smaller dishes clumped into one large 
cell clump.  Tissue culture plastic coated dishes were not detrimental to sphere 




The growth factor bFGF is required for MSC-sphere formation.  Cultures that did not 
receive bFGF during induction, did not form spheres and many cells died within a few 
days.  The addition of retinoic acid (RA) during induction prevented sphere formation, 
however, it did not break up MSC-spheres which were already formed.  The addition of 
nerve growth factor (NGF), brain derived neurotrophic factor (BDNF), neurotrophin-3 
(NT-3), or epidermal growth factor (EGF) either alone or in combination was not 





MSCs induced in conditioned media from NSCs formed MSC-spheres, but since 
conditioned media is variable based on the culture it is obtained from, we decided to use 
a more defined, reproducible media.  MSC-spheres were plated in conditioned media 
from primary neurons, astrocytes, and co-cultures, but for the same reason, this line of 
experiments was discontinued. 
 
Extracellular Matrix Proteins 
While MSC-spheres adhered to fibronectin, laminin, collagen I, and collagen IV, this did 
not increase their sphere formation and may have even inhibited it. 
 113 
REFERENCES 
"The 2007 Guidelines fro the Management of Severe Traumatic Brain Injury." J 
Neurotrauma 24 Suppl 1: S1-106. 
Abramoff, M. D. and M. A. Viergever (2002). "Computation and visualization of three-
dimensional soft tissue motion in the orbit." IEEE Trans Med Imaging 21(4): 296-304. 
Bartholomew, A., C. Sturgeon, et al. (2002). "Mesenchymal stem cells suppress 
lymphocyte proliferation in vitro and prolong skin graft survival in vivo." Exp Hematol 
30(1): 42-8. 
Bass, N. H., H. H. Hess, et al. (1971). "Quantitative cytoarchitectonic distribution of 
neurons, glia, and DNa in rat cerebral cortex." J Comp Neurol 143(4): 481-90. 
Behravesh, E., K. Emami, et al. (2005). "Comparison of genotoxic damage in monolayer 
cell cultures and three-dimensional tissue-like cell assemblies." Adv Space Res 35(2): 
260-7. 
Benya, P. D. and J. D. Shaffer (1982). "Dedifferentiated chondrocytes reexpress the 
differentiated collagen phenotype when cultured in agarose gels." Cell 30(1): 215-24. 
Birgersdotter, A., R. Sandberg, et al. (2005). "Gene expression perturbation in vitro--a 
growing case for three-dimensional (3D) culture systems." Semin Cancer Biol 15(5): 
405-12. 
Bjorklund, A. (2005). "Cell therapy for Parkinson's disease: problems and prospects." 
Novartis Found Symp 265: 174-86; discussion 187, 204-211. 
Bjornson, C. R., R. L. Rietze, et al. (1999). "Turning brain into blood: a hematopoietic 
fate adopted by adult neural stem cells in vivo." Science 283(5401): 534-7. 
Bramlett, H. M. and W. D. Dietrich (2002). "Quantitative structural changes in white and 
gray matter 1 year following traumatic brain injury in rats." Acta Neuropathol (Berl) 
103(6): 607-14. 
Brazelton, T. R., F. M. Rossi, et al. (2000). "From marrow to brain: expression of 
neuronal phenotypes in adult mice." Science 290(5497): 1775-9. 
Bursac, N., M. Papadaki, et al. (2003). "Cultivation in rotating bioreactors promotes 
maintenance of cardiac myocyte electrophysiology and molecular properties." Tissue 
Eng 9(6): 1243-53. 
Buschmann, M. D., Y. A. Gluzband, et al. (1992). "Chondrocytes in agarose culture 
synthesize a mechanically functional extracellular matrix." J Orthop Res 10(6): 745-58. 
Byrnes, K. R. and A. I. Faden (2007). "Role of Cell Cycle Proteins in CNS Injury." 
Neurochem Res. 
 114 
Castillon, N., J. Hinnrasky, et al. (2002). "Polarized expression of cystic fibrosis 
transmembrane conductance regulator and associated epithelial proteins during the 
regeneration of human airway surface epithelium in three-dimensional culture." Lab 
Invest 82(8): 989-98. 
CDC. (1999). "Epidemiology of traumatic brain injury in the United States." from 
www.cdc.gov. 
Cernak, I. (2005). "Animal models of head trauma." NeuroRx 2(3): 410-22. 
Chauhan, N. B., H. M. Figlewicz, et al. (1999). "Carbon filaments direct the growth of 
postlesional plastic axons after spinal cord injury." Int J Dev Neurosci 17(3): 255-64. 
Chen, X., M. Katakowski, et al. (2002). "Human bone marrow stromal cell cultures 
conditioned by traumatic brain tissue extracts: growth factor production." J Neurosci Res 
69(5): 687-91. 
Chun, T. H., K. B. Hotary, et al. (2006). "A pericellular collagenase directs the 3-
dimensional development of white adipose tissue." Cell 125(3): 577-91. 
Ciccolini, F. (2001). "Identification of two distinct types of multipotent neural precursors 
that appear sequentially during CNS development." Mol Cell Neurosci 17(5): 895-907. 
Ciccolini, F. and C. N. Svendsen (1998). "Fibroblast growth factor 2 (FGF-2) promotes 
acquisition of epidermal growth factor (EGF) responsiveness in mouse striatal precursor 
cells: identification of neural precursors responding to both EGF and FGF-2." J Neurosci 
18(19): 7869-80. 
Coates, P. W., B. Fermini, et al. (1992). "Utilization of three-dimensional culture for early 
morphometric and electrophysiological analyses of solitary cerebellar neurons." Dev 
Neurosci 14(1): 35-43. 
Cogle, C. R., A. T. Yachnis, et al. (2004). "Bone marrow transdifferentiation in brain after 
transplantation: a retrospective study." Lancet 363(9419): 1432-7. 
Conti, A. C., R. Raghupathi, et al. (1998). "Experimental brain injury induces regionally 
distinct apoptosis during the acute and delayed post-traumatic period." J Neurosci 
18(15): 5663-5672. 
Corti, S., F. Locatelli, et al. (2003). "Neuronal generation from somatic stem cells: current 
knowledge and perspectives on the treatment of acquired and degenerative central 
nervous system disorders." Curr Gene Ther 3(3): 247-72. 
Crigler, L., R. C. Robey, et al. (2006). "Human mesenchymal stem cell subpopulations 
express a variety of neuro-regulatory molecules and promote neuronal cell survival and 
neuritogenesis." Exp Neurol 198(1): 54-64. 
Cukierman, E., R. Pankov, et al. (2001). "Taking cell-matrix adhesions to the third 
dimension." Science 294(5547): 1708-12. 
 115 
Cullen, D. K. and M. C. LaPlaca (2006). "Neuronal response to high rate shear 
deformation depends on heterogeneity of the local strain field." J Neurotrauma 23(9): 
1304-19. 
Cullen, D. K., M. C. Lessing, et al. (2007a). "Collagen-dependent neurite outgrowth and 
response to dynamic deformation in three-dimensional neuronal cultures." Ann Biomed 
Eng 35(5): 835-46. 
Cullen, D. K., Simon, C.M., LaPlaca, M.C. ((in press)-a). "Strain rate-dependent 
induction of reactive astrogliosis and cell death in three-dimensional neuronal-astrocytic 
co-cultures." Brain Research. 
Cullen, D. K., Stabenfeldt, S.E., Simon, C.M., Tate, C.C., LaPlaca, M.C. ((in press)-b). 
"An In Vitro Neural Injury Model for Optimization of Tissue Engineered Constructs." 
Journal of Neuroscience Research. 
Cullen, D. K., J. Vukasinovic, et al. (2007b). "Microfluidic engineered high cell density 
three-dimensional neural cultures." J Neural Eng 4(2): 159-72. 
Danen, E. H. and K. M. Yamada (2001). "Fibronectin, integrins, and growth control." J 
Cell Physiol 189(1): 1-13. 
Desai, A., W. S. Kisaalita, et al. (2006). "Human neuroblastoma (SH-SY5Y) cell culture 
and differentiation in 3-D collagen hydrogels for cell-based biosensing." Biosens 
Bioelectron 21(8): 1483-92. 
Dezawa, M. (2006). "Insights into autotransplantation: the unexpected discovery of 
specific induction systems in bone marrow stromal cells." Cell Mol Life Sci 63(23): 2764-
72. 
Dixon, C. E., G. L. Clifton, et al. (1991). "A controlled cortical impact model of traumatic 
brain injury in the rat." J Neurosci Methods 39(3): 253-62. 
Fletcher, T. L., P. Cameron, et al. (1991). "The distribution of synapsin I and 
synaptophysin in hippocampal neurons developing in culture." J Neurosci 11(6): 1617-
1626. 
Fox, G. B., L. Fan, et al. (1998). "Sustained sensory/motor and cognitive deficits with 
neuronal apoptosis following controlled cortical impact brain injury in the mouse." J 
Neurotrauma 15(8): 599-614. 
Fried, A., A. Shamay, et al. (1996). "Phenotypic expression of marrow cells when grown 
on various substrata." J Cell Biochem 61(2): 246-254. 
Friedl, P., K. S. Zanker, et al. (1998). "Cell migration strategies in 3-D extracellular 
matrix: differences in morphology, cell matrix interactions, and integrin function." Microsc 
Res Tech 43(5): 369-78. 
Gao, Q., Y. Li, et al. (2005). "Bone marrow stromal cells increase astrocyte survival via 
upregulation of phosphoinositide 3-kinase/threonine protein kinase and mitogen-
activated protein kinase kinase/extracellular signal-regulated kinase pathways and 
 116 
stimulate astrocyte trophic factor gene expression after anaerobic insult." Neuroscience 
136(1): 123-34. 
Glennie, S., I. Soeiro, et al. (2005). "Bone marrow mesenchymal stem cells induce 
division arrest anergy of activated T cells." Blood 105(7): 2821-7. 
Grinnell, F., L. B. Rocha, et al. (2006). "Nested collagen matrices: a new model to study 
migration of human fibroblast populations in three dimensions." Exp Cell Res 312(1): 86-
94. 
Gronthos, S., P. J. Simmons, et al. (2001). "Integrin-mediated interactions between 
human bone marrow stromal precursor cells and the extracellular matrix." Bone 28(2): 
174-81. 
Guan, K., H. Chang, et al. (2001). "Embryonic stem cell-derived neurogenesis. Retinoic 
acid induction and lineage selection of neuronal cells." Cell Tissue Res 305(2): 171-6. 
Hempstead, B. L. (2006). "Dissecting the diverse actions of pro- and mature 
neurotrophins." Curr Alzheimer Res 3(1): 19-24. 
Hermann, A., R. Gastl, et al. (2004). "Efficient generation of neural stem cell-like cells 
from adult human bone marrow stromal cells." J Cell Sci 117(Pt 19): 4411-22. 
Herzog, E. L., L. Chai, et al. (2003). "Plasticity of marrow-derived stem cells." Blood 
102(10): 3483-93. 
Hindie, M., M. Vayssade, et al. (2006). "Interactions of B16F10 melanoma cells 
aggregated on a cellulose substrate." J Cell Biochem 99(1): 96-104. 
Jiang, Y., B. N. Jahagirdar, et al. (2002a). "Pluripotency of mesenchymal stem cells 
derived from adult marrow." Nature 418(6893): 41-9. 
Jiang, Y., B. Vaessen, et al. (2002b). "Multipotent progenitor cells can be isolated from 
postnatal murine bone marrow, muscle, and brain." Exp Hematol 30(8): 896-904. 
Kallos, M. S., A. Sen, et al. (2003). "Large-scale expansion of mammalian neural stem 
cells: a review." Med Biol Eng Comput 41(3): 271-82. 
Kim, B. J., J. H. Seo, et al. (2002). "Differentiation of adult bone marrow stem cells into 
neuroprogenitor cells in vitro." Neuroreport 13(9): 1185-8. 
Kim, D. S., J. Y. Kim, et al. (2007). "Derivation of functional dopamine neurons from 
embryonic stem cells." Cell Transplant 16(2): 117-23. 
Kimura, T., N. Yasui, et al. (1984). "Chondrocytes embedded in collagen gels maintain 
cartilage phenotype during long-term cultures." Clin Orthop Relat Res(186): 231-9. 
Kiryushko, D., V. Berezin, et al. (2004). "Regulators of neurite outgrowth: role of cell 
adhesion molecules." Ann N Y Acad Sci 1014: 140-54. 
Kleinman, H. K., M. L. McGarvey, et al. (1986). "Basement membrane complexes with 
biological activity." Biochemistry 25(2): 312-8. 
 117 
Kornblum, H. I. (2007). "Introduction to neural stem cells." Stroke 38(2 Suppl): 810-6. 
Koutouzis, T. K., D. F. Emerich, et al. (1994). "Cell transplantation for central nervous 
system disorders." Crit Rev Neurobiol 8(3): 125-62. 
Labbe, R., A. Firl, Jr., et al. (1983). "Fetal brain transplant: reduction of cognitive deficits 
in rats with frontal cortex lesions." Science 221(4609): 470-2. 
LaPlaca, M. C., D. K. Cullen, et al. (2005). "High rate shear strain of three-dimensional 
neural cell cultures: a new in vitro traumatic brain injury model." J Biomech 38(5): 1093-
105. 
Le Blanc, K., I. Rasmusson, et al. (2004). "Treatment of severe acute graft-versus-host 
disease with third party haploidentical mesenchymal stem cells." Lancet 363(9419): 
1439-41. 
Le Blanc, K., C. Tammik, et al. (2003). "HLA expression and immunologic properties of 
differentiated and undifferentiated mesenchymal stem cells." Exp Hematol 31(10): 890-6. 
Lim, D. A., Y. C. Huang, et al. (2007). "The adult neural stem cell niche: lessons for 
future neural cell replacement strategies." Neurosurg Clin N Am 18(1): 81-92, ix. 
Lindvall, O. and A. Bjorklund (2004). "Cell therapy in Parkinson's disease." NeuroRx 
1(4): 382-93. 
Liu, C. T., Y. J. Yang, et al. (2006a). "The immunobiological development of human bone 
marrow mesenchymal stem cells in the course of neuronal differentiation." Cell Immunol 
244(1): 19-32. 
Liu, H., J. Lin, et al. (2006b). "Effect of 3D scaffold and dynamic culture condition on the 
global gene expression profile of mouse embryonic stem cells." Biomaterials 27(36): 
5978-89. 
Loers, G. and M. Schachner (2007). "Recognition molecules and neural repair." J 
Neurochem. 
Longhi, L., E. R. Zanier, et al. (2005). "Stem cell transplantation as a therapeutic strategy 
for traumatic brain injury." Transpl Immunol 15(2): 143-8. 
Lu, D., Y. Li, et al. (2002). "Neural and marrow-derived stromal cell sphere 
transplantation in a rat model of traumatic brain injury." J Neurosurg 97(4): 935-40. 
Lu, D., A. Mahmood, et al. (2001). "Adult bone marrow stromal cells administered 
intravenously to rats after traumatic brain injury migrate into brain and improve 
neurological outcome." Neuroreport 12(3): 559-63. 
Luo, Y. and M. S. Shoichet (2004). "A photolabile hydrogel for guided three-dimensional 
cell growth and migration." Nat Mater 3(4): 249-53. 
 118 
Mahmood, A., D. Lu, et al. (2004). "Marrow stromal cell transplantation after traumatic 
brain injury promotes cellular proliferation within the brain." Neurosurgery 55(5): 1185-
93. 
Mahmood, A., D. Lu, et al. (2006). "Long-term recovery after bone marrow stromal cell 
treatment of traumatic brain injury in rats." J Neurosurg 104(2): 272-7. 
Mao, C. and W. S. Kisaalita (2004). "Characterization of 3-D collagen hydrogels for 
functional cell-based biosensing." Biosens Bioelectron 19(9): 1075-88. 
Marklund, N., A. Bakshi, et al. (2006). "Evaluation of pharmacological treatment 
strategies in traumatic brain injury." Curr Pharm Des 12(13): 1645-80. 
McIntosh, T. K., K. E. Saatman, et al. (1998). "The Dorothy Russell Memorial Lecture. 
The molecular and cellular sequelae of experimental traumatic brain injury: pathogenetic 
mechanisms." Neuropathol Appl Neurobiol 24(4): 251-67. 
Mezey, E. and K. J. Chandross (2000). "Bone marrow: a possible alternative source of 
cells in the adult nervous system." Eur J Pharmacol 405(1-3): 297-302. 
Mezey, E., K. J. Chandross, et al. (2000). "Turning blood into brain: cells bearing 
neuronal antigens generated in vivo from bone marrow." Science 290(5497): 1779-82. 
Mezey, E., S. Key, et al. (2003). "Transplanted bone marrow generates new neurons in 
human brains." Proc Natl Acad Sci U S A 100(3): 1364-9. 
Morales, D. M., N. Marklund, et al. (2005). "Experimental models of traumatic brain 
injury: do we really need to build a better mousetrap?" Neuroscience 136(4): 971-89. 
O'Connor, S. M., J. D. Andreadis, et al. (2000a). "Immobilization of neural cells in three-
dimensional matrices for biosensor applications." Biosens Bioelectron 14(10-11): 871-
81. 
O'Connor, S. M., J. D. Andreadis, et al. (2000b). "Immobilization of neural cells in three-
dimensional matrices for biosensor applications." Biosens Bioelectron 14(10-11): 871-
81. 
O'Connor, S. M., D. A. Stenger, et al. (2001). "Survival and neurite outgrowth of rat 
cortical neurons in three-dimensional agarose and collagen gel matrices." Neurosci Lett 
304(3): 189-93. 
O'Shaughnessy, T. J., H. J. Lin, et al. (2003). "Functional synapse formation among rat 
cortical neurons grown on three-dimensional collagen gels." Neurosci Lett 340(3): 169-
72. 
Pancrazio, J. J., J. P. Whelan, et al. (1999). "Development and application of cell-based 
biosensors." Ann Biomed Eng 27(6): 697-711. 
Patz, S. and P. Wahle (2004). "Neurotrophins induce short-term and long-term changes 
of cortical neurotrophin expression." Eur J Neurosci 20(3): 701-8. 
 119 
Pedersen, J. A. and M. A. Swartz (2005). "Mechanobiology in the third dimension." Ann 
Biomed Eng 33(11): 1469-90. 
Peister, A., J. A. Mellad, et al. (2004). "Adult stem cells from bone marrow (MSCs) 
isolated from different strains of inbred mice vary in surface epitopes, rates of 
proliferation, and differentiation potential." Blood 103(5): 1662-8. 
Pierce, J. E., D. H. Smith, et al. (1998). "Enduring cognitive, neurobehavioral and 
histopathological changes persist for up to one year following severe experimental brain 
injury in rats." Neuroscience 87(2): 359-69. 
Prockop, D. J. (1997). "Marrow stromal cells as stem cells for nonhematopoietic tissues." 
Science 276(5309): 71-4. 
Qian, L. and W. M. Saltzman (2004). "Improving the expansion and neuronal 
differentiation of mesenchymal stem cells through culture surface modification." 
Biomaterials 25(7-8): 1331-7. 
Riess, P., M. Molcanyi, et al. (2007). "Embryonic stem cell transplantation after 
experimental traumatic brain injury dramatically improves neurological outcome, but may 
cause tumors." J Neurotrauma 24(1): 216-25. 
Roberts, I., G. Schierhout, et al. (1998). "Absence of evidence for the effectiveness of 
five interventions routinely used in the intensive care management of severe head injury: 
a systematic review." J Neurol Neurosurg Psychiatry 65(5): 729-33. 
Rosen, G. D. and J. D. Harry (1990). "Brain volume estimation from serial section 
measurements: a comparison of methodologies." J Neurosci Methods 35(2): 115-24. 
Saporta, S., C. Borlongan, et al. (1997). "Microcarrier enhanced survival of human and 
rat fetal ventral mesencephalon cells implanted in the rat striatum." Cell Transplant 6(6): 
579-84. 
Schindler, M., E. K. A. Nur, et al. (2006). "Living in three dimensions: 3D nanostructured 
environments for cell culture and regenerative medicine." Cell Biochem Biophys 45(2): 
215-27. 
Schouten, J. W., C. T. Fulp, et al. (2004). "A review and rationale for the use of cellular 
transplantation as a therapeutic strategy for traumatic brain injury." J Neurotrauma 
21(11): 1501-38. 
Seledtsov, V. I., S. S. Rabinovich, et al. (2005). "Cell transplantation therapy in re-
animating severely head-injured patients." Biomed Pharmacother 59(7): 415-20. 
Shear, D. A., M. C. Tate, et al. (2004). "Neural progenitor cell transplants promote long-
term functional recovery after traumatic brain injury." Brain Res 1026(1): 11-22. 
Sinson, G., M. Voddi, et al. (1996). "Combined fetal neural transplantation and nerve 
growth factor infusion: effects on neurological outcome following fluid-percussion brain 
injury in the rat." J Neurosurg 84(4): 655-62. 
 120 
Smalley, K. S., M. Lioni, et al. (2006). "Life isn't flat: taking cancer biology to the next 
dimension." In Vitro Cell Dev Biol Anim 42(8-9): 242-7. 
Sostak, P., D. Theil, et al. (2007). "Detection of bone marrow-derived cells expressing a 
neural phenotype in the human brain." J Neuropathol Exp Neurol 66(2): 110-6. 
Spilker, M. H., K. Asano, et al. (2001). "Contraction of collagen-glycosaminoglycan 
matrices by peripheral nerve cells in vitro." Biomaterials 22(10): 1085-93. 
Stabenfeldt, S. E., A. J. Garcia, et al. (2006). "Thermoreversible laminin-functionalized 
hydrogel for neural tissue engineering." J Biomed Mater Res A. 
Stein, D. G. (1991). "Fetal brain tissue grafting as therapy for brain dysfunctions: 
Unanswered questions, unknown factors, and practical concerns." J Neurosurg 
Anesthesiol 3(3): 170-89. 
Stein, D. G. and M. M. Glasier (1995). "Some Practical and Theoretical Issues 
Concerning Fetal Brain- Tissue Grafts As Therapy For Brain Dysfunctions." Behavioral 
and Brain Sciences 18(1): 36-45. 
Subramanian, T. (2001). "Cell transplantation for the treatment of Parkinson's disease." 
Semin Neurol 21(1): 103-15. 
Tang, Y., T. Yasuhara, et al. (2007). "Transplantation of bone marrow-derived stem 
cells: a promising therapy for stroke." Cell Transplant 16(2): 159-69. 
Tate, M. C., A. J. Garcia, et al. (2004). "Specific beta1 integrins mediate adhesion, 
migration, and differentiation of neural progenitors derived from the embryonic striatum." 
Mol Cell Neurosci 27(1): 22-31. 
Tate, M. C., D. A. Shear, et al. (2002). "Fibronectin promotes survival and migration of 
primary neural stem cells transplanted into the traumatically injured mouse brain." Cell 
Transplant 11(3): 283-95. 
Tate, M. C., D. A. Shear, et al. (2001). "Biocompatibility of methylcellulose-based 
constructs designed for intracerebral gelation following experimental traumatic brain 
injury." Biomaterials 22(10): 1113-23. 
Taupin, P. (2006). "Autologous transplantation in the central nervous system." Indian J 
Med Res 124(6): 613-8. 
Thurman, D. (2001). Epidemiology and economics of head trauma. Head trauma 
therapeutics: basic, preclinical and clinical aspects. L. Miller and R. L. Hayes. New York, 
NY, John Wiley and Sons. 
Thurman, D. J., C. Alverson, et al. (1999). "Traumatic brain injury in the United States: A 
public health perspective." J Head Trauma Rehabil 14(6): 602-15. 
Tsacopoulos, M. and P. J. Magistretti (1996). "Metabolic coupling between glia and 
neurons." J Neurosci 16(3): 877-85. 
 121 
Ullian, E. M., S. K. Sapperstein, et al. (2001). "Control of synapse number by glia." 
Science 291(5504): 657-61. 
Venstrom, K. A. and L. F. Reichardt (1993). "Extracellular matrix. 2: Role of extracellular 
matrix molecules and their receptors in the nervous system." Faseb J 7(11): 996-1003. 
Verfaillie, C. M. (2002). "Adult stem cells: assessing the case for pluripotency." Trends 
Cell Biol 12(11): 502-8. 
Verfaillie, C. M., R. Schwartz, et al. (2003). "Unexpected potential of adult stem cells." 
Ann N Y Acad Sci 996: 231-4. 
Verma, A. (2000). "Opportunities for neuroprotection in traumatic brain injury." J Head 
Trauma Rehabil 15(5): 1149-61. 
Vukicevic, S., H. K. Kleinman, et al. (1992). "Identification of multiple active growth 
factors in basement membrane Matrigel suggests caution in interpretation of cellular 
activity related to extracellular matrix components." Exp Cell Res 202(1): 1-8. 
Warden, D. (2006). "Military TBI during the Iraq and Afghanistan wars." J Head Trauma 
Rehabil 21(5): 398-402. 
Watts, C. and S. B. Dunnett (2000). "Towards a protocol for the preparation and delivery 
of striatal tissue for clinical trials of transplantation in Huntington's disease." Cell 
Transplant 9(2): 223-34. 
Willerth, S. M., K. J. Arendas, et al. (2006). "Optimization of fibrin scaffolds for 
differentiation of murine embryonic stem cells into neural lineage cells." Biomaterials 
27(36): 5990-6003. 
Williams, R. W. and K. Herrup (1988). "The control of neuron number." Annu Rev 
Neurosci 11: 423-53. 
Winkler, C., D. Kirik, et al. (2005). "Cell transplantation in Parkinson's disease: how can 
we make it work?" Trends Neurosci 28(2): 86-92. 
Wong, J., N. W. Hoe, et al. (2005). "Apoptosis and traumatic brain injury." Neurocrit Care 
3(2): 177-82. 
Wu, Z. Z., Y. P. Zhao, et al. (2006). "A packed Cytodex microbead array for three-
dimensional cell-based biosensing." Biosens Bioelectron 22(5): 685-93. 
Xu, T., C. A. Gregory, et al. (2006). "Viability and electrophysiology of neural cell 
structures generated by the inkjet printing method." Biomaterials 27(19): 3580-8. 
Yamada, K. M., R. Pankov, et al. (2003). "Dimensions and dynamics in integrin 
function." Braz J Med Biol Res 36(8): 959-66. 
Yefang, Z., D. W. Hutmacher, et al. (2007). "Comparison of human alveolar osteoblasts 
cultured on polymer-ceramic composite scaffolds and tissue culture plates." Int J Oral 
Maxillofac Surg 36(2): 137-45. 
 122 
Yu, X., G. P. Dillon, et al. (1999). "A laminin and nerve growth factor-laden three-
dimensional scaffold for enhanced neurite extension." Tissue Eng 5(4): 291-304. 
Zhang, X., Y. Chen, et al. (2005). "Bench-to-bedside review: Apoptosis/programmed cell 
death triggered by traumatic brain injury." Crit Care 9(1): 66-75. 
 
  
 
